<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 201905//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8068269</article-id><article-id pub-id-type="pmid">33917820</article-id><article-id pub-id-type="doi">10.3390/antibiotics10040403</article-id><article-id pub-id-type="publisher-id">antibiotics-10-00403</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Biosynthesis and Heterologous Expression of Cacaoidin, the First Member of the Lanthidin Family of RiPPs</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3270-3627</contrib-id><name><surname>Rom&#x000e1;n-Hurtado</surname><given-names>Fernando</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1920-8242</contrib-id><name><surname>S&#x000e1;nchez-Hidalgo</surname><given-names>Marina</given-names></name><xref rid="c1-antibiotics-10-00403" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Mart&#x000ed;n</surname><given-names>Jes&#x000fa;s</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9410-3718</contrib-id><name><surname>Ortiz-L&#x000f3;pez</surname><given-names>Francisco Javier</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4202-1219</contrib-id><name><surname>Genilloud</surname><given-names>Olga</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Simal-Gandara</surname><given-names>Jesus</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-antibiotics-10-00403">Fundaci&#x000f3;n MEDINA, Avenida del Conocimiento, 34, 18016 Granada, Spain; <email>fernando.roman@medinaandalucia.es</email> (F.R.-H.); <email>jesus.martin@medinaandalucia.es</email> (J.M.); <email>javier.ortiz@medinaandalucia.es</email> (F.J.O.-L.); <email>olga.genilloud@medinaandalucia.es</email> (O.G.)</aff><author-notes><corresp id="c1-antibiotics-10-00403"><label>*</label>Correspondence: <email>marina.sanchez@medinaandalucia.es</email></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>4</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2021</year></pub-date><volume>10</volume><issue>4</issue><elocation-id>403</elocation-id><history><date date-type="received"><day>22</day><month>3</month><year>2021</year></date><date date-type="accepted"><day>06</day><month>4</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cacaoidin is produced by the strain <italic>Streptomyces cacaoi</italic> CA-170360 and represents the first member of the new lanthidin (class V lanthipeptides) RiPP family. In this work, we describe the complete identification, cloning and heterologous expression of the cacaoidin biosynthetic gene cluster, which shows unique RiPP genes whose functions were not predicted by any bioinformatic tool. We also describe that the cacaoidin pathway is restricted to strains of the subspecies <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> found in public genome databases, where we have also identified the presence of other putative class V lanthipeptide pathways. This is the first report on the heterologous production of a class V lanthipeptide.</p></abstract><kwd-group><kwd>cacaoidin</kwd><kwd>lanthidin</kwd><kwd>class V lanthipeptide</kwd><kwd>RiPP</kwd><kwd><italic>Streptomyces cacaoi</italic></kwd><kwd>heterologous expression</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antibiotics-10-00403"><title>1. Introduction</title><p>Actinomycetes are an extremely diverse group of Gram-positive, filamentous bacteria with high GC content genomes [<xref rid="B1-antibiotics-10-00403" ref-type="bibr">1</xref>] considered as one of the most prolific sources for the discovery of new natural products (NPs) [<xref rid="B2-antibiotics-10-00403" ref-type="bibr">2</xref>,<xref rid="B3-antibiotics-10-00403" ref-type="bibr">3</xref>]. Among all the actinomycetes, the genus <italic>Streptomyces</italic> produces over 70&#x02013;80% of the secondary metabolites with described therapeutic properties [<xref rid="B4-antibiotics-10-00403" ref-type="bibr">4</xref>].</p><p>The increasing number of sequenced genomes has revealed that actinomycetes carry the genetic potential to produce many more secondary metabolites than those detected under laboratory conditions [<xref rid="B5-antibiotics-10-00403" ref-type="bibr">5</xref>]. The development of bioinformatic tools to identify the presence of new secondary metabolite Biosynthetic Gene Clusters (BGCs) from genome sequences, such as antiSMASH [<xref rid="B6-antibiotics-10-00403" ref-type="bibr">6</xref>] or MIBiG [<xref rid="B7-antibiotics-10-00403" ref-type="bibr">7</xref>], among others [<xref rid="B8-antibiotics-10-00403" ref-type="bibr">8</xref>], has permitted the development of targeted genome mining strategies directed at variants of specific families of compounds [<xref rid="B9-antibiotics-10-00403" ref-type="bibr">9</xref>]. Among them, Ribosomally synthesized and Post-translationally modified Peptides (RiPPs) show more structural diversity than initially predicted from genome sequences [<xref rid="B10-antibiotics-10-00403" ref-type="bibr">10</xref>]. Most RiPPs are synthesized as a longer precursor peptide, containing a C-terminal core peptide that undergoes a broad diversity of Post-Translational Modifications (PTMs) directed by the N-terminal leader peptide [<xref rid="B11-antibiotics-10-00403" ref-type="bibr">11</xref>].</p><p>We have recently described the discovery of cacaoidin, a novel glycosylated lantibiotic produced by the strain <italic>Streptomyces cacaoi</italic> CA-170360 [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>]. Cacaoidin represents the first reported member of lanthidins, also known as the new class V lanthipeptides, exhibiting remarkable structural features, such as a lanthionine ring and N-terminal dimethylation, restricted thus far to lanthipeptide [<xref rid="B13-antibiotics-10-00403" ref-type="bibr">13</xref>] and linaridin [<xref rid="B14-antibiotics-10-00403" ref-type="bibr">14</xref>,<xref rid="B15-antibiotics-10-00403" ref-type="bibr">15</xref>,<xref rid="B16-antibiotics-10-00403" ref-type="bibr">16</xref>] RiPP families, respectively, in an unprecedented <italic>N</italic>,<italic>N</italic>-dimethyl lanthionine system (NMe<sub>2</sub>Lan) [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>] (<xref ref-type="fig" rid="antibiotics-10-00403-f001">Figure 1</xref>). In addition, cacaoidin contains several PTMs, some of them shared with other lanthipeptides, such as a C-terminal S-[(Z)-2-aminovinyl-3-methyl]-<sc>d</sc>-cysteine (AviMeCys) amino acid. AviMeCys is formed in lanthipeptides through an oxidative decarboxylation of the C-terminal cysteine by LanD and the resulting reactive thio&#x02013;enol intermediate cyclises with a Dhb residue, yielding AviMeCys [<xref rid="B17-antibiotics-10-00403" ref-type="bibr">17</xref>]. This differs from the AviCys formation in linaridins [<xref rid="B18-antibiotics-10-00403" ref-type="bibr">18</xref>], which occurs between two cysteine residues and is catalyzed by LinD [<xref rid="B19-antibiotics-10-00403" ref-type="bibr">19</xref>]. The co-existing structural features restricted to lanthipeptides and linaridins have supported the proposal of cacaoidin as the first reported member of the lanthidins [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>]. Cacaoidin also presents other unusual structural features, such as a high number of <sc>d-</sc>amino acids and an O-glycosylated tyrosine residue carrying a non-previously reported disaccharide formed by &#x003b1;-<sc>l</sc>-rhamnose and &#x003b2;-<sc>l</sc>-6-deoxygulose [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>].</p><p>Shortly after the discovery of cacaoidin, Xu et al. [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>] described the novel RiPP lexapeptide as the first member of the new class V lanthipeptide. Lexapeptide is structurally similar to cacaoidin since it contains an N-terminal <italic>N</italic>,<italic>N</italic>-dimethylation, a C-terminal AviMeCys moiety and a <sc>d-</sc>Ala. According to this, and to the new RiPP classification established in a recent review [<xref rid="B21-antibiotics-10-00403" ref-type="bibr">21</xref>], cacaoidin is the founding member of the class V lanthipeptides, firstly reported by our group as lanthidins.</p><p>In this work, we present the identification and analysis of the cacaoidin BGC from the genome analysis of <italic>Streptomyces cacaoi</italic> CA-170360, showing its distinct gene cluster organization. We show that the BGC proposed contains all the genes required for cacaoidin biosynthesis that was successfully produced via heterologous expression. To our knowledge, this is the first class V lanthipeptide to be heterologously produced. We also describe that the cacaoidin BGC is a species-specific trait within the genus <italic>Streptomyces</italic> and identify the presence of other class V lanthipeptide pathways in public genome databases.</p></sec><sec sec-type="results" id="sec2-antibiotics-10-00403"><title>2. Results</title><sec id="sec2dot1-antibiotics-10-00403"><title>2.1. Sequencing of Streptomyces Cacaoi CA-170360 Genome and Identification of Cacaoidin BGC</title><p><italic>S. cacaoi</italic> CA-170360 genome sequence was obtained with a combination of <italic>de novo</italic> PacBio and Illumina approaches, yielding two contigs of 5,971,081 bp and 2,704,105 bp.</p><p>The genome sequence was analyzed with antiSMASH [<xref rid="B6-antibiotics-10-00403" ref-type="bibr">6</xref>], BAGEL4 [<xref rid="B22-antibiotics-10-00403" ref-type="bibr">22</xref>] and PRISM [<xref rid="B23-antibiotics-10-00403" ref-type="bibr">23</xref>], but none of these tools could predict the BGC responsible for cacaoidin biosynthesis, suggesting that the discovery of novel bioactive NPs using genome mining is still a challenge [<xref rid="B10-antibiotics-10-00403" ref-type="bibr">10</xref>].</p><p>The C-terminal sequence of cacaoidin (Thr-Ala-Ser-Trp-Gly-Cys) was used as the query in a tBLASTn using the whole genome sequence. A 162 bp Open Reading Frame (ORF) was found to encode this sequence and helped to elucidate the final structure of the peptide [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>]. Cacaoidin structural gene <italic>caoA</italic> encodes a 23-amino acid C-terminal core peptide (SSAPCTIYASVSASISATASWGC) following a predicted 30-amino acid N-terminal leader peptide (MGEVVEMVAGFDTYADVEELNQIAVGEAPE). Neither the leader nor the core peptide sequences showed high sequence similarity with any other lanthipeptide or linaridin (<xref ref-type="app" rid="app1-antibiotics-10-00403">Figure S1</xref>).</p><p>Considering the structure of cacaoidin [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>] (<xref ref-type="fig" rid="antibiotics-10-00403-f001">Figure 1</xref>), we identified a putative 30 Kb BGC (<italic>cao</italic> cluster) containing 27 ORFs whose proposed functions were assigned after BLAST analysis and HHpred secondary structure prediction (<xref ref-type="fig" rid="antibiotics-10-00403-f002">Figure 2</xref>, <xref rid="antibiotics-10-00403-t001" ref-type="table">Table 1</xref> and <xref ref-type="app" rid="app1-antibiotics-10-00403">Table S2</xref>). Interestingly, no homologous genes of known dehydratases or cyclases commonly found in the four classes described for lanthipeptides nor in the class of linaridins could be identified in this region. Moreover, the similarity with the recently described lexapeptide BGC (<italic>lxm</italic>) [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>] contributed as well to assigning some of the functions of the <italic>cao</italic> ORFs.</p><p>The <italic>cao</italic> BGC encodes a putative cypemycin decarboxylase CypD homologue (CaoD) containing a conserved phosphopantothenoylcysteine (PPC) synthetase/decarboxylase domain [<xref rid="B17-antibiotics-10-00403" ref-type="bibr">17</xref>,<xref rid="B24-antibiotics-10-00403" ref-type="bibr">24</xref>]. CaoD shares a 54.8% similarity with LxmD from the lexapeptide BGC, which is involved in the decarboxylation of C-terminal Cys residue during the formation of the AviMeCys moiety [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>], a fact that supports the same role for CaoD.</p><p>The formation of lanthionine rings is accomplished by different dehydratases and cyclases depending on the lanthipeptide class [<xref rid="B15-antibiotics-10-00403" ref-type="bibr">15</xref>], but no homologues were found in the <italic>cao</italic> cluster. In the lexapeptide biosynthesis, a three-component lanthionine synthetase formed by the standalone monofunctional proteins LxmK, LxmX and LxmY is responsible for the Ser/Thr dehydration and cyclization to form Dha and Dhb, respectively, and the installation of the lanthionine ring [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>]. These proteins present a certain degree of homology with some proteins encoded in the <italic>cao</italic> cluster: LxmK shows a 49.6% similarity with Cao9, LxmX has a 40.5% similarity with Cao14 and LxmY shows a 44.9% similarity with Cao7. Interestingly, LxmY and Cao7 contain a HopA1 conserved domain (PFAM17914) that has been described in the HopA1 effector protein from <italic>Pseudomonas syringae</italic> [<xref rid="B25-antibiotics-10-00403" ref-type="bibr">25</xref>].</p><p>According to these data, Cao7-9-14 would also work as a three-component lanthionine synthetase: the putative kinase Cao9 would phosphorylate Ser/Thr residues on the CaoA precursor peptide, Cao14 would remove the phosphate groups and generate dehydro-amino acids, and Cao7 would catalyze a Michael-type addition of the Cys5 thiol group to the &#x003b2;-carbon of Dha1, generating the lanthionine bridge, and likely the addition of previously decarboxylated-Cys23 by CaoD to Dhb18, forming AviMeCys.</p><p>The N-terminal Ala dimethylation of cypemycin, the prototypical member of linaridins [<xref rid="B18-antibiotics-10-00403" ref-type="bibr">18</xref>], is carried out by the S-adenosylmethionine (SAM)-dependent methyltransferase CypM [<xref rid="B14-antibiotics-10-00403" ref-type="bibr">14</xref>,<xref rid="B19-antibiotics-10-00403" ref-type="bibr">19</xref>] and shows homology with the methyltransferase LxmM that catalyzes the lexapeptide N-terminal dimethylation [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>]. The <italic>cao</italic> cluster encodes Cao4, a putative O-methyltransferase containing the conserved Methyltransf_2 domain. However, despite the low homology found between Cao4 and LxmM (26.9% similarity), both proteins share the AdoMet_MTases superfamily domain, characteristic of the SAM-dependent methyltransferases. No other CypM or LxmM homologues have been found in the genome of strain CA-170360. Cao4 shows very low homology with two types of LanS O-methyltransferases described in class I lanthipeptide clusters from actinobacteria: LanS<sub>A</sub> [<xref rid="B26-antibiotics-10-00403" ref-type="bibr">26</xref>] and LanS<sub>B</sub> [<xref rid="B27-antibiotics-10-00403" ref-type="bibr">27</xref>]. Thus, its role in the <italic>N</italic>,<italic>N</italic>-methylation remains unclear and is currently under study.</p><p><sc>d</sc>-Amino acids provide a wide variety of properties to lanthipeptides [<xref rid="B28-antibiotics-10-00403" ref-type="bibr">28</xref>] and are introduced by modifying the genetically encoded <sc>l</sc>-Ser and <sc>l</sc>-Thr into Dha and Dhb, which are subjected to a diastereoselective hydrogenation to finally incorporate <sc>d</sc>-Ala and <sc>d</sc>-Abu, respectively [<xref rid="B15-antibiotics-10-00403" ref-type="bibr">15</xref>,<xref rid="B27-antibiotics-10-00403" ref-type="bibr">27</xref>]. This reaction is carried out by dehydrogenases generically called LanJ [<xref rid="B15-antibiotics-10-00403" ref-type="bibr">15</xref>], which are divided into zinc-dependent dehydrogenases (LanJ<sub>A</sub>), which can only hydrogenate Dha, and flavin-dependent dehydrogenases (LanJ<sub>B</sub>) able to reduce both Dha and Dhb [<xref rid="B29-antibiotics-10-00403" ref-type="bibr">29</xref>,<xref rid="B30-antibiotics-10-00403" ref-type="bibr">30</xref>]. Xu et al. [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>] reported LxmJ as the first example of the LanJ<sub>C</sub> class in lanthipeptides. LxmJ is a novel F<sub>420</sub>H<sub>2</sub>-dependent reductase that catalyzes the stereospecific reduction of Dha28 to <sc>d</sc>-Ala28 in the mature lexapeptide. Within the <italic>cao</italic> BGC, Cao12 shows a 58,6% similarity with LxmJ, and both proteins contain a F<sub>420</sub>H<sub>2</sub>-dependent oxidoreductase (MSMEG_4879 family) conserved domain. This suggests that Cao12 could be also involved in the incorporation of <sc>d</sc>-amino acids (four <sc>d</sc>-Ala and one <sc>d</sc>-Abu) in the cacaoidin structure. It has been demonstrated that LxmJ is unable to reduce Dhb when a S28T point mutation is introduced in LxmA. However, as it was shown for BsjJ<sub>B</sub> in bicereucin biosynthesis [<xref rid="B30-antibiotics-10-00403" ref-type="bibr">30</xref>], the reduction may be dependent of the position and/or sequence, so the incorporation of <sc>d</sc>-Abu in cacaoidin could also be performed by Cao12.</p><p>The disaccharide moiety <italic>&#x003b2;</italic>-6-deoxygulopyranosyl-(1&#x02192;3)-&#x003b1;-rhamnopyranoside of cacaoidin has not been previously reported [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>]. Three of the four proteins required for the synthesis of <italic>&#x003b1;</italic>-<sc>l</sc>-rhamnose (<italic>rmlA, rmlB</italic> and <italic>rmlD</italic>) (<xref ref-type="app" rid="app1-antibiotics-10-00403">Figure S2</xref>) are encoded in the <italic>cao</italic> cluster. Nevertheless, a BLAST search of RmlC against CA-170360 whole genome sequence also shows the presence of a <italic>rmlC</italic> gene and additional <italic>rmlA, rmlB</italic> and <italic>rmlD</italic> homologous genes outside the cacaoidin cluster. Indeed, it has been reported that the <italic>rml</italic> genes do not have to be necessarily clustered [<xref rid="B31-antibiotics-10-00403" ref-type="bibr">31</xref>]. Bleomycin, tallysomycin and zorbamycin incorporate NDP-<sc>l</sc>-gulose or NDP-6-deoxy-<sc>l</sc>-gulose to their structures, and their biosynthesis was used as reference to look for the presence of similar proteins being encoded in our genome (<xref ref-type="app" rid="app1-antibiotics-10-00403">Figure S3</xref>) [<xref rid="B32-antibiotics-10-00403" ref-type="bibr">32</xref>]. Despite no homologues being found in the cacaoidin BGC, we identified some protein homologues in the genome. However, as none of them were clustered, no conclusions could be made for the <italic>&#x003b2;</italic>-<sc>l</sc>-6-deoxy-gulose biosynthesis.</p><p>As one of the unusual structural features of cacaoidin, the disaccharide is O-linked to the aromatic ring of the tyrosine residue [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>]. While serine, threonine or hydroxyproline O-glycosylation have been reported in many natural glycopeptides [<xref rid="B33-antibiotics-10-00403" ref-type="bibr">33</xref>], the O-glycosylation of tyrosine in a natural product has been only reported in the mannopeptimycins, in a reaction catalyzed by the mannosyltransferases MppH and MppI [<xref rid="B34-antibiotics-10-00403" ref-type="bibr">34</xref>]. The <italic>cao</italic> cluster lacks MppH/I homologues, but contains three glycosyltransferases (GTs) (Cao8, Cao16 and Cao24). Cao8 and Cao16 belong to the family GT-2 and show 42% identity (54% similarity) and 43% identity (52% similarity), respectively, with an UDP-Glc:alpha-<sc>d</sc>-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD, which catalyzes the addition of Glc, the second sugar moiety of the O152-antigen repeating unit, to GlcNAc-pyrophosphate-undecaprenol [<xref rid="B35-antibiotics-10-00403" ref-type="bibr">35</xref>]. In contrast, Cao24 belongs to the family GT-4 that has a GT4_GtfA-like domain and a conserved RfaB domain, involved in the cell wall and membrane biosynthesis [<xref rid="B36-antibiotics-10-00403" ref-type="bibr">36</xref>].</p><p>Despite the presence of three GTs in the cacaoidin BGC, only two sugar moieties in the form of disaccharide are detected in the structure. The three GTs could work in a cooperative manner to achieve effective glycosylation, as it has already been proposed [<xref rid="B37-antibiotics-10-00403" ref-type="bibr">37</xref>,<xref rid="B38-antibiotics-10-00403" ref-type="bibr">38</xref>,<xref rid="B39-antibiotics-10-00403" ref-type="bibr">39</xref>]. Based on the &#x0201c;inverting&#x0201d; or &#x0201c;retaining&#x0201d; behavior of the glycosyltransferases, we propose that both Cao8 and Cao16, belonging to the &#x0201c;inverting&#x0201d; GT-2 family, might work cooperatively to attach the &#x003b1;-<sc>l</sc>-rhamnose unit, while Cao24, belonging to the &#x0201c;retaining&#x0201d; GT-4 family, would incorporate the <italic>&#x003b2;</italic>-<sc>l</sc>-6-deoxygulose unit [<xref rid="B12-antibiotics-10-00403" ref-type="bibr">12</xref>].</p><p>In addition to cacaoidin, only two glycosylated RiPPs produced by bacteria have been described: the group of glycocins, whose sugar moieties are linked to Cys, Ser or Thr residues by S-glycosyltransferases [<xref rid="B40-antibiotics-10-00403" ref-type="bibr">40</xref>], and the class III lanthipeptide NAI-112, which carries a 6-deoxyhexose moiety N-linked to a tryptophan residue by the AplG GT [<xref rid="B41-antibiotics-10-00403" ref-type="bibr">41</xref>]. However, low homologies were found between these enzymes and the GTs present in the cacaoidin cluster. Further studies will clarify the role of each GT in cacaoidin biosynthesis.</p><p>Processing of leader peptide is another key step in the post-translational modification of RiPPs [<xref rid="B15-antibiotics-10-00403" ref-type="bibr">15</xref>,<xref rid="B42-antibiotics-10-00403" ref-type="bibr">42</xref>,<xref rid="B43-antibiotics-10-00403" ref-type="bibr">43</xref>,<xref rid="B44-antibiotics-10-00403" ref-type="bibr">44</xref>,<xref rid="B45-antibiotics-10-00403" ref-type="bibr">45</xref>,<xref rid="B46-antibiotics-10-00403" ref-type="bibr">46</xref>]. In the cacaoidin cluster, Cao15 encodes a putative Zn-dependent peptidase belonging to the M16 peptidase family that may be involved in the leader peptide processing. Peptidases LxmP1 and LxmP2 from lexapeptide BGC also belong to the M16 peptidase family and share 25.4% and 30.4% similarity with Cao15, respectively. LxmP1 has an inactive M16 peptidase domain and LxmP2 an active domain. It has been suggested that LxmP1 and LxmP2 may form a heterodimer to remove the leader peptide from LxmA [<xref rid="B20-antibiotics-10-00403" ref-type="bibr">20</xref>]. Since Cao15 harbors both the active and the inactive M16 peptidase domains, we propose Cao15 as the cacaoidin leader peptidase.</p><p>Furthermore, three ABC transporters were found in the <italic>cao</italic> pathway (Cao11, Cao18 and Cao19) that might be responsible for the export and self-resistance of cacaoidin, as it has been proposed in other lanthipeptides [<xref rid="B47-antibiotics-10-00403" ref-type="bibr">47</xref>,<xref rid="B48-antibiotics-10-00403" ref-type="bibr">48</xref>].</p><p>Gene expression in the cacaoidin cluster seems to be under the control of five different transcriptional regulators: one LuxR (CaoR1), two HTH-type XRE (CaoR2 and CaoR3), one TetR (CaoR4) and one SARP (CaoR5). XRE and TetR have been described as transcriptional repressors [<xref rid="B49-antibiotics-10-00403" ref-type="bibr">49</xref>,<xref rid="B50-antibiotics-10-00403" ref-type="bibr">50</xref>] while LuxR and SARP have been designated as transcriptional activators [<xref rid="B51-antibiotics-10-00403" ref-type="bibr">51</xref>,<xref rid="B52-antibiotics-10-00403" ref-type="bibr">52</xref>]. Further studies will clarify their role in the production of the antibiotic.</p><p>The remaining five genes identified in the <italic>cao</italic> cluster (<italic>cao17</italic>, <italic>cao21</italic>, <italic>cao23</italic>, <italic>cao25</italic> and <italic>cao26</italic>) do not have any defined functions. Cao23 belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) superfamily of proteins [<xref rid="B53-antibiotics-10-00403" ref-type="bibr">53</xref>,<xref rid="B54-antibiotics-10-00403" ref-type="bibr">54</xref>]. This superfamily contains aromatase/cyclase (ARO/CYC) domains, such as those described for tetracenomycin [<xref rid="B55-antibiotics-10-00403" ref-type="bibr">55</xref>] and Smu.440 [<xref rid="B56-antibiotics-10-00403" ref-type="bibr">56</xref>]. However, we cannot still propose a function for Cao23.</p><p>The HHpred analysis of each ORF was also used for the detection of RiPP precursor peptide Recognition Elements (RREs) [<xref rid="B57-antibiotics-10-00403" ref-type="bibr">57</xref>]. These RRE are structurally similar PqqD-related conserved precursor peptide-binding domains present in the majority of known prokaryotic RiPP modifying enzymes and are usually responsible for the leader peptide recognition [<xref rid="B57-antibiotics-10-00403" ref-type="bibr">57</xref>,<xref rid="B58-antibiotics-10-00403" ref-type="bibr">58</xref>,<xref rid="B59-antibiotics-10-00403" ref-type="bibr">59</xref>]. However, no RREs were found, suggesting the possibility of alternative leader peptide recognition domains that are unrelated to the already known RREs [<xref rid="B57-antibiotics-10-00403" ref-type="bibr">57</xref>]. As homology detection algorithms become more accurate and more sequences become available, additional RREs will be found.</p></sec><sec id="sec2dot2-antibiotics-10-00403"><title>2.2. Cloning and Heterologous Expression of Cacaoidin BGC</title><p>The strain <italic>S. cacaoi</italic> CA-170360 is reluctant to genetic manipulation, limiting the obtention of knockdown mutants to confirm the involvement of the <italic>cao</italic> gene cluster in the biosynthesis of cacaoidin. To confirm that the genes included in the <italic>cao</italic> cluster were sufficient for biosynthesis of the antibiotic, we cloned and heterologously expressed the cacaoidin BGC in the genetically amenable host <italic>Streptomyces albus</italic> J1074 [<xref rid="B60-antibiotics-10-00403" ref-type="bibr">60</xref>].</p><p>We followed the CATCH method [<xref rid="B61-antibiotics-10-00403" ref-type="bibr">61</xref>] to clone a 40 Kb region containing the <italic>cao</italic> BGC into the pCAP01 vector [<xref rid="B62-antibiotics-10-00403" ref-type="bibr">62</xref>], yielding pCAO. pCAO was introduced into NEB-10-beta <italic>E. coli</italic> ET12567 cells via electroporation. A triparental conjugation [<xref rid="B63-antibiotics-10-00403" ref-type="bibr">63</xref>] was carried out between <italic>E. coli</italic> ET12567/pCAO, <italic>E. coli</italic> ET12567/pUB307 and <italic>S. albus</italic> J1074 spores [<xref rid="B60-antibiotics-10-00403" ref-type="bibr">60</xref>]. The transconjugants were genetically verified via PCR amplification of the genes <italic>cao4</italic>, <italic>cao8</italic> and <italic>cao15</italic> using specific primers described in <xref ref-type="app" rid="app1-antibiotics-10-00403">Table S1</xref>. Five positive transconjugants, alongside the negative control (<italic>S. albus</italic> J1074/pCAP01) and the wild-type strain CA-170360, were grown in R2YE, MPG, FR23, YEME and KM4 for 14 days at 28 &#x000b0;C to confirm the production of the targeted antibiotic. After acetone extraction of the cultures, organic solvent was evaporated, and the aqueous extracts containing 20% DMSO were analyzed via LC-HRESIMS(+)-TOF and MS/MS.</p><p>The analysis of the extracts from pCAO transconjugants confirmed the presence of peaks at 3.35 min, coincident with the retention time of elution of cacaoidin in the wild-type strain and purified cacaoidin standards, only in R2YE medium. The perfect correlation between the UV spectrum, exact mass, isotopic distribution and MS/MS fragmentation patterns of cacaoidin standards and the components isolated from <italic>S. albus</italic> J1074/pCAO, undoubtedly demonstrated that they correspond to cacaoidin (<xref ref-type="fig" rid="antibiotics-10-00403-f003">Figure 3</xref> and <xref ref-type="fig" rid="antibiotics-10-00403-f004">Figure 4</xref>). We quantified the yield of cacaoidin production in both the heterologous and the wild-type strains. <italic>S. albus</italic> J1074 has been largely used as heterologous host to produce a broad range of compound classes with improved yields [<xref rid="B64-antibiotics-10-00403" ref-type="bibr">64</xref>]. However, the cacaoidin production yield of 0.14 mg/L in the heterologous strain grown in R2YE was reduced approximately 4-fold with respect to the 0.57 mg/L obtained in the wild-type strain CA-170360 in the same medium and fermentation format (10 mL). These results clearly confirm that the <italic>cao</italic> BGC cloned in pCAO contains all the genes required to ensure the biosynthesis of cacaoidin, although the production yield is dependent on the strain used.</p></sec><sec id="sec2dot3-antibiotics-10-00403"><title>2.3. Additional Lanthidin Clusters in Public Databases</title><p>To study if more lanthidin-encoding clusters can be found within actinomycetes, a BLAST search against the NCBI whole genome shotgun sequences database was performed, and sequences with a high degree of homology to cacaoidin BGC were only found in five <italic>Streptomyces</italic> strains, namely <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> NRRL B-1220 (MUBL01000486), <italic>Streptomyces</italic> sp. NRRL F-5053 (JOHT01000009), <italic>Streptomyces</italic> sp. NRRL S-1868 (JOGD01000003), <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> NBRC 12748 (BJMM01000002.1) and <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> OABC16 (VSKT010000024) (<xref ref-type="fig" rid="antibiotics-10-00403-f005">Figure 5</xref>, <xref ref-type="app" rid="app1-antibiotics-10-00403">Table S3</xref>).</p><p>An alignment of the precursor peptide of the cacaoidin in all homologous clusters showed that no variations in the protein sequence were found. No other cacaoidin-derived peptides or pathways were found in the databases, indicating that the cacaoidin BGC is very conserved. A phylogenetic tree generated using the neighbor-joining method and corrected with the Tamura 3-parameter algorithm [<xref rid="B65-antibiotics-10-00403" ref-type="bibr">65</xref>,<xref rid="B66-antibiotics-10-00403" ref-type="bibr">66</xref>] showed the close relatedness of strain <italic>Streptomyces cacaoi</italic> CA-170360 with the other five strains that contain the <italic>cao</italic> cluster, which was highly supported by the bootstrap values and contained two sequences of the type species of <italic>S.cacaoi</italic> subsp <italic>cacaoi</italic> NRRL B-1220 and NBRC 12748, as well as the strain of the same subspecies, OABC16 (<xref ref-type="app" rid="app1-antibiotics-10-00403">Figure S4</xref>). Moreover, when the 16S rDNA sequences of the unclassified strains <italic>Streptomyces</italic> sp. NRRL F-5053 and <italic>Streptomyces</italic> sp. NRRL S-1868 were analyzed in EzBiocloud, a 100% sequence similarity was confirmed with <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> NRRL B-1220, indicating that the cacaoidin BGC is so far limited to this specific clade of highly related strains associated to the subspecies <italic>S. cacaoi</italic> subsp. <italic>cacaoi</italic>, with no identifiable orthologs in other <italic>Streptomyces</italic> species. We extended the study to other members of the subspecies <italic>S.cacaoi</italic> subsp. <italic>asoensis</italic> that are clustered in a very distant phylogenetic branch from <italic>S.cacaoi</italic> subsp. <italic>cacaoi</italic> (<xref ref-type="app" rid="app1-antibiotics-10-00403">Figure S4</xref>). We could confirm that none of the three whole genome sequences available in NCBI from strains of <italic>S. cacaoi</italic> subsp. <italic>asoensis</italic> contained any region with homology with the <italic>cao</italic> cluster, supporting that the <italic>cao</italic> BGC is a characteristic trait of the subspecies <italic>S. cacaoi</italic> subsp <italic>cacaoi</italic>. Several genome comparative studies have found other species-specific BGCs in some species of <italic>Streptomyces</italic>, reflecting that chemical novelty can be found at the species level and that the analysis of the genomes of closely related strains constitutes a promising approach for the identification of novel BGCs [<xref rid="B67-antibiotics-10-00403" ref-type="bibr">67</xref>,<xref rid="B68-antibiotics-10-00403" ref-type="bibr">68</xref>]. The occurrence of these species-specific BGCs may suggest that they were acquired recently via horizontal gene transfer as it has been shown for other pathways [<xref rid="B69-antibiotics-10-00403" ref-type="bibr">69</xref>].</p><p>Nevertheless, the analysis of below-threshold scores of CaoA BLAST results, together with the search of HopA1 domain-containing proteins similar to Cao7, allowed us to find some additional pathways that could encode new lanthidins (<xref ref-type="fig" rid="antibiotics-10-00403-f006">Figure 6</xref>). The alignment of the hypothetical precursor peptides shows the presence of some conserved residues that possibly could be involved in the leader peptide recognition by biosynthetic enzymes (<xref ref-type="fig" rid="antibiotics-10-00403-f007">Figure 7</xref>). In addition, the analysis of the ORFs present in all these clusters shows that all of them share a HopA1 domain-containing protein, a F<sub>420</sub>H<sub>2</sub>-dependent oxidoreductase, a CypD-related protein, a Zn-dependent or S9 peptidase and a putative phosphotransferase (<xref ref-type="fig" rid="antibiotics-10-00403-f006">Figure 6</xref>). Most of these clusters also contain an O-methyltransferase. These preliminary data suggest the existence of a minimal set of genes required to ensure the core structural features of a lanthidin and a broader distribution of potential BGCs encoding new lanthidins. These putative lanthidin BGCs are mainly present in <italic>Streptomyces</italic> strains, but also in two <italic>Actinoplanes</italic> species and another undefined member of the class <italic>Actinobacteria</italic>. To date, only the class V lanthipeptides cacaoidin and lexapeptide BGCs have been described. Additional members of the proposed new RiPP family will need to be isolated to confirm this hypothesis and whether class V lanthipeptides are only present in <italic>Actinobacteria</italic> (<xref ref-type="fig" rid="antibiotics-10-00403-f007">Figure 7</xref>).</p></sec></sec><sec id="sec3-antibiotics-10-00403"><title>3. Materials and Methods</title><sec id="sec3dot1-antibiotics-10-00403"><title>3.1. Strains and Plasmids</title><p>The strain <italic>Streptomyces cacaoi</italic> CA-170360, from Fundaci&#x000f3;n MEDINA&#x02019;s Culture Collection, was isolated from the rhizosphere of <italic>Brownanthus corallinus</italic>, in the region of Namaqualand (South Africa). Electrocompetent NEB 10-&#x003b2; <italic>E. coli</italic> (New England BioLabs, Ipswich, MA, USA), <italic>E. coli</italic> ET12567 (LGC Standards, Manchester, NH, USA) and <italic>E. coli</italic> ET12567/pUB307 (kindly provided by Jos&#x000e9; Antonio Salas) were used for plasmid transformation and intergeneric triparental conjugation. <italic>Streptomyces albus</italic> J1074 [<xref rid="B60-antibiotics-10-00403" ref-type="bibr">60</xref>], also kindly provided by Jos&#x000e9; Antonio Salas, was employed as the heterologous expression host.</p><p>Vector pCAP01, a yeast-<italic>E. coli</italic>-actinobacteria shuttle vector that can integrate cloned gene clusters into the genome of heterologous actinobacteria hosts due to its site-specific &#x003c6;C31 integrase [<xref rid="B70-antibiotics-10-00403" ref-type="bibr">70</xref>], was used for the cloning of the cacaoidin BGC and was a gift from Bradley Moore (Addgene plasmid #59981; <uri xlink:href="http://n2t.net/addgene:59981">http://n2t.net/addgene:59981</uri> (accessed on 12 January 2021); RRID: Addgene_59981).</p></sec><sec id="sec3dot2-antibiotics-10-00403"><title>3.2. DNA Extraction and Genome Mining</title><p>Genomic DNA of the strain <italic>Streptomyces cacaoi</italic> CA-170360 was extracted and purified as Kieser et al. described [<xref rid="B63-antibiotics-10-00403" ref-type="bibr">63</xref>] from cultures on ATCC-2 liquid medium (soluble starch 20 g/L, glucose 10 g/L, NZ Amine Type E 5 g/L, meat extract 3 g/L, peptone 5 g/L, yeast extract 5 g/L, calcium carbonate 1 g/L, pH 7) grown on an orbital shaker at 28 &#x000b0;C, 220 rpm and 70% relative humidity.</p><p>The genome of CA-170360 was fully sequenced <italic>de novo</italic>, assembled and annotated by Macrogen (Seoul, Korea; <uri xlink:href="http://www.macrogen.com/">http://www.macrogen.com/</uri> (accessed on 12 January 2021)), using a combined strategy of Illumina HiSeq 2500 and PacBio RSII platforms. The PacBio long-reads were assembled with Canu (v1.7) [<xref rid="B71-antibiotics-10-00403" ref-type="bibr">71</xref>]. After assembly, Illumina reads were applied for accurate genome sequence using Pilon (v1.21) [<xref rid="B72-antibiotics-10-00403" ref-type="bibr">72</xref>]. To validate the accuracy of the assembly, Illumina reads were mapped to the assembly result. After mapping, the consensus sequence was generated.</p></sec><sec id="sec3dot3-antibiotics-10-00403"><title>3.3. Identification of Cacaoidin BGC</title><p>The sequence of the CA-170360 genome was analyzed with antiSMASH v4.2.0 [<xref rid="B6-antibiotics-10-00403" ref-type="bibr">6</xref>], BAGEL4 [<xref rid="B22-antibiotics-10-00403" ref-type="bibr">22</xref>], PRISM [<xref rid="B23-antibiotics-10-00403" ref-type="bibr">23</xref>] and RiPPMiner [<xref rid="B73-antibiotics-10-00403" ref-type="bibr">73</xref>] in order to find cacaoidin BGC. BLAST (Basic Local Alignment Search Tool) [<xref rid="B74-antibiotics-10-00403" ref-type="bibr">74</xref>] and HHpred based on profile hidden Markov model (HMM) comparisons [<xref rid="B75-antibiotics-10-00403" ref-type="bibr">75</xref>] were also employed to predict the function of each gene in the biosynthesis of the lanthipeptide. The <italic>cao</italic> BGC sequence is available in the National Center for Biotechnology Information (NCBI) database under accession GenBank number MT210103.</p></sec><sec id="sec3dot4-antibiotics-10-00403"><title>3.4. Cas-9 Assisted Targeting of CHromosome (CATCH) Cloning of Cacaoidin BGC</title><p>Cloning of cacaoidin BGC was performed via CATCH. The CRISPR-Cas9 endonuclease is guided by an RNA template to cleave specific DNA targets enabling larger BGC to be isolated than other techniques such as transformation-associated recombination or single-strand overlapping annealing [<xref rid="B61-antibiotics-10-00403" ref-type="bibr">61</xref>].</p><p>The CATCH cloning was performed as Jian and Zhu described [<xref rid="B76-antibiotics-10-00403" ref-type="bibr">76</xref>]. First, we designed the 20 nt targeted sequences flanking the BGC with the CRISPy-web tool (<uri xlink:href="http://crispy.secondarymetabolites.org/">http://crispy.secondarymetabolites.org/</uri> (accessed on 12 January 2021)). This computational tool design guides RNAs close to a PAM (Protospacer-Adjacent Motif) sequence &#x02018;NGG&#x02019; [<xref rid="B77-antibiotics-10-00403" ref-type="bibr">77</xref>] and we performed an overlapping PCR with the Q5 High-Fidelity polymerase from New England BioLabs (Ipswich, MA, USA), and used one specific primer within the 20 nt targeted sequence (X-sgRNA-P) and two universal primers (sgRNA-F and sgRNA-R). We obtained the sgRNA using the HiScribe T7 Quick Yield RNA synthesis kit (New England Biolabs). We also performed a PCR using the pCAP01 vector as backbone with primers containing a 20 nt sequence that anneals to the template plasmid and a 30 nt overhang overlapping with both ends of the BGC, and this PCR product was treated with DpnI (New England BioLabs) to cleave the template plasmid. Primers used for CATCH cloning are described in <xref ref-type="app" rid="app1-antibiotics-10-00403">Table S1</xref>.</p><p><italic>S. cacaoi</italic> CA-170360 was cultured in ATCC-2 for 2 days on an orbital shaker at 28 &#x000b0;C, 220 rpm and 70% relative humidity and the bacterial cells were embedded in low-melting agarose plugs to make the subsequent in-gel digestion with Cas9 more feasible. The plugs were treated with lysozyme, proteinase K and washing buffers, and the in-gel Cas9 digestion was performed by mixing two agarose plugs, a cleavage buffer (100 mM HEPES pH 7.5, 750 mM KCl, 0.5 mM EDTA pH 8, 50 mM MgCl2, DEPC-treated water), the sgRNAs and the Cas9 nuclease from <italic>S. pyogenes</italic> (New England BioLabs) and incubating at 37 &#x000b0;C for 2 h. After this time the agarose plugs were melted and digested with gelase and the cleavaged DNA was precipitated with ethanol and resuspended in DNase-free water.</p><p>The Cas9-digested DNA was cloned into the vector pCAP01 via Gibson Assembly using a 2&#x000d7; Gibson Assembly Master Mix (New England BioLabs) and incubating at 50 &#x000b0;C for 1 h. After the ligation, this Gibson product (pCAO) was transformed into electrocompetent NEB-10-beta <italic>E. coli</italic> cells. These cells were incubated in 1 mL LB broth Miller (Sigma, St. Louis, MO, USA) (37 &#x000b0;C, 250 rpm) without antibiotics and plated on Difco LB agar Lennox (37 &#x000b0;C, overnight, static) containing kanamycin (50 &#x003bc;g/mL).</p><p>The plasmids obtained from the selected colonies on these LB agar plates were validated by performing two independent double digestions with HindIII/NdeI and XbaI/EcoRV restriction endonucleases from New England BioLabs, which gave two different fragmentation patterns that allowed us to identify the correct pCAO construction.</p></sec><sec id="sec3dot5-antibiotics-10-00403"><title>3.5. Heterologous Expression of Cacaoidin BGC</title><p>Construction pCAO was introduced into <italic>Streptomyces albus</italic> J1074 host via triparental conjugation [<xref rid="B61-antibiotics-10-00403" ref-type="bibr">61</xref>]. First, <italic>E. coli</italic> ET12567 cells were electroporated with 50 ng of the construction in a total volume of 1 &#x000b5;L and plated on selective LB agar plates with 50 &#x000b5;g/mL kanamycin. <italic>E. coli</italic> ET12567/pUB307 cells were also streaked on selective LB agar plates with 50 &#x000b5;g/mL kanamycin and 25 &#x000b5;g/mL chloramphenicol, which were incubated at 37 &#x000b0;C overnight. <italic>E. coli</italic> ET12567/pCAO and ET12567/pUB307 cells were collected at an OD<sub>600</sub> of 0.4&#x02013;0.6, washed three times with LB liquid medium without antibiotics supplementation, suspended with 100 &#x000b5;L LB liquid medium and mixed with 50 &#x000b5;L of previously activated spores (incubated at 50 &#x000b0;C for 10 min) of <italic>S. albus</italic> J1074. These mixtures were plated onto MA plates and incubated at 28 &#x000b0;C overnight (around 16 h). On the next day, the conjugation MA plates were overlayed with 1.5 mL of sterilized Milli-Q water containing 50 &#x000b5;g/mL kanamycin and 25 &#x000b5;g/mL nalidixic acid. These plates were incubated again at 28 &#x000b0;C for 3&#x02013;5 days to let the exconjugants grow. After this time of incubation, five exconjugants from each <italic>Streptomyces</italic> heterologous host were picked and spread out on MA plates containing nalidixic acid (25 &#x003bc;g/mL) and kanamycin (50 &#x003bc;g/mL).</p><p>Five plugs from these MA plates of the recombinant strain <italic>S. albus</italic> J1074/pCAO were used to seed 10 mL ATCC-2 tubes, which were incubated at 28 &#x000b0;C for 2&#x02013;3 days, 220 rpm and 70% humidity, and these cultures, together with the corresponding negative controls harboring empty pCAP01 vector, were used to inoculate 10 mL of MPG (10 g/L glucose, 20 g/L Millet meal, 20 g/L MOPS, 20 g/L pharmamedia, pH 7.0), R2YE (103 g/L sucrose, 0.25 g /L K<sub>2</sub>SO<sub>4</sub>, 10.12 g/L MgCl<sub>2</sub>&#x02219;6H<sub>2</sub>O, 10 g/L glucose, 0.1 g/L Difco Casaminoacids, 0.05 g/L KH<sub>2</sub>PO<sub>4</sub>, 2.944 g/L CaCl<sub>2</sub>&#x02219;2H<sub>2</sub>O, 3 g/L <sc>l</sc>-proline, 5.73 g/L TES buffer, 5 g/L Difco yeast extract, 5 mL 1N NaOH, 2 mL trace elements), KM4 (4 g/L glucose, 4 g/L yeast extract, 10 g/L malt extract, 2 g/L CaCO<sub>3</sub>) (12), YEME (3 g/L yeast extract, 3 g/L malt extract, 5 g/L peptone, 10 g/L glucose, 340 g/L sucrose) and FR23 (5 g/L glucose, 30 g/L soluble starch from potato, 20 g/L cottonseed flour, 20 g/L cane molasses, pH 7) fermentation media. These fermentations were incubated at 28 &#x000b0;C, 220 rpm and 70% humidity for 14 days.</p></sec><sec id="sec3dot6-antibiotics-10-00403"><title>3.6. Extraction and Detection of Cacaoidin</title><p>Cultures of the recombinant strain <italic>S. albus</italic> J1074/pCAO, together with the negative control harboring empty pCAP01 vector, were subjected to extraction with acetone 1:1 under continuous shaking at 220 rpm for 2 h. The organic solvent with the secondary metabolites extracted was separated from the biomass via centrifugation, the acetone was removed by a stream of nitrogen overnight and the extracts were resuspended to a final ratio of 20% DMSO/water. The resulting microbial extracts were filtered and analyzed using LC-HRESIMS(+)-TOF and MS/MS.</p></sec><sec id="sec3dot7-antibiotics-10-00403"><title>3.7. Extraction and Detection of Cacaoidin</title><p>Standard solutions of pure cacaoidin at different concentrations were prepared in 20% DMSO, and a calibration curve was obtained based on the intensity of the LC-MS peak areas (slope = 245491, Y-intercept= &#x02212;6165.4, R<sup>2</sup> = 0.9996). Cacaoidin concentrations from the R2YE culture extracts were determined by interpolating their LC-MS peak areas on the calibration curve (y = 245941x &#x02212; 6165.4).</p></sec></sec><sec sec-type="conclusions" id="sec4-antibiotics-10-00403"><title>4. Conclusions</title><p>Cacaoidin is the first member of the new lanthidin (class V lanthipeptides) RiPP family characterized by the combination of structural features thus far restricted to lanthipeptide and linaridin families and encoded by a new unprecedented RiPP BGC organization that could not be predicted using antiSMASH, BAGEL4 or any other bioinformatic tool. The lack of homology with common lanthionine ring formation or double N-terminal dimethylation enzymes suggests an alternative mechanism of biosynthesis that may be similar to that of the recently described lanthidin lexapeptide. The other unusual structural features of cacaoidin, such as the high number of <sc>d</sc>-amino acids or the O-glycosylation of tyrosine are supported by the presence in the <italic>cao</italic> cluster of protein homologues of a F<sub>420</sub>H<sub>2</sub>-dependent oxidoreductase and three glycosyltransferases. The heterologous expression of cacaoidin BGC has demonstrated that the <italic>cao</italic> cluster contains all the necessary genes to biosynthesize this molecule, and future research is needed to clarify the unassigned functions of the <italic>cao</italic> genes.</p><p>Cacaoidin BGC was only found in the genomes of all publicly available <italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic> strains and not in any other species, suggesting that this cluster may be a species-specific trait. Undoubtedly, cacaoidin BGC has an unprecedented genetic organization, completely different from any other previously described RiPP cluster. Moreover, the detection of similar putative lanthidin homologous clusters opens the door to the study of a new exciting family of RiPPs.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank Daniel Oves-Costales and Fernando Reyes for helpful advice during the whole process and the Microbiology and Chemistry areas of Fundaci&#x000f3;n MEDINA for the technical support. We thank Jos&#x000e9; Antonio Salas and the University of Oviedo for kindly providing strains <italic>Streptomyces albus</italic> J1074 and <italic>Escherichia coli</italic> ET12567/pUB307.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-antibiotics-10-00403"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/article/10.3390/antibiotics10040403/s1">https://www.mdpi.com/article/10.3390/antibiotics10040403/s1</uri>, Table S1: Primers used for the cloning and checking of the <italic>cao</italic> biosynthetic gene cluster, Table S2: Closest HHpred homolog for each ORF in cacaoidin BGC, Table S3: BLAST homology between the ORFs in cacaoidin BGC and NCBI found clusters, Figure S1: Alignment the structural amino acidic sequence of cacaoidin with the sequences of other already known lanthipeptides and linaridins, Figure S2: Schematic presentation of the biosynthesis of dTDP-<sc>l</sc>-rhamnose from <sc>d</sc>-glucose, Figure S3: Proposed pathway for the <italic>&#x003b2;</italic>-<sc>l</sc>-6-deoxy-gulose sugar biosynthesis for the BLM, TLM and ZMB compounds, Figure S4: Neighbor-joining tree built with Mega X based on nearly complete 16S rRNA gene sequences of CA-170360, the 50 closest type strains of the genus <italic>Streptomyces</italic> and three strains of <italic>Streptomyces cacaoi</italic> subsp. <italic>asoensis</italic>.</p><supplementary-material content-type="local-data" id="antibiotics-10-00403-s001"><media xlink:href="antibiotics-10-00403-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>F.R.-H., M.S.-H. and O.G. conceived and designed the experiments and wrote the paper. F.R.-H. performed the genetic experiments and bioinformatic analysis. J.M. performed the LC-HRESIMS(+)-TOF and MS/MS experiments. F.J.O.-L. confirmed the structures of the compound and contributed to discussion of the sugar biosynthesis and glycosylation and to writing the paper. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by Novo Nordisk Foundation, grant number: NF16OC0021746.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data presented in this study are openly available in NCBI, GenBank reference number [MT210103]. Publicly available datasets were analyzed in this study. These data can be found in NCBI, GenBank reference numbers [MUBL00000000.1, VSKT00000000.1, JOGD00000000.1, JOHT00000000.1 and BJMM00000000.1].</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-10-00403"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barka</surname><given-names>E.A.</given-names></name><name><surname>Vatsa</surname><given-names>P.</given-names></name><name><surname>Sanchez</surname><given-names>L.</given-names></name><name><surname>Gaveau-Vaillant</surname><given-names>N.</given-names></name><name><surname>Jacquard</surname><given-names>C.</given-names></name><name><surname>Meier-Kolthoff</surname><given-names>J.P.</given-names></name><name><surname>Klenk</surname><given-names>H.-P.</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>C.</given-names></name><name><surname>Ouhdouch</surname><given-names>Y.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name></person-group><article-title>Taxonomy, Physiology, and Natural Products of <italic>Actinobacteria</italic></article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2015</year><volume>80</volume><fpage>1</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00019-15</pub-id><pub-id pub-id-type="pmid">26609051</pub-id></element-citation></ref><ref id="B2-antibiotics-10-00403"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berdy</surname><given-names>J.</given-names></name></person-group><article-title>Bioactive microbial metabolites</article-title><source>J. Antibiot.</source><year>2005</year><volume>58</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/ja.2005.1</pub-id><?supplied-pmid 15813176?><pub-id pub-id-type="pmid">15813176</pub-id></element-citation></ref><ref id="B3-antibiotics-10-00403"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genilloud</surname><given-names>O.</given-names></name></person-group><article-title>Actinomycetes: Still a source of novel antibiotics</article-title><source>Nat. Prod. Rep.</source><year>2017</year><volume>34</volume><fpage>1203</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1039/C7NP00026J</pub-id><?supplied-pmid 28820533?><pub-id pub-id-type="pmid">28820533</pub-id></element-citation></ref><ref id="B4-antibiotics-10-00403"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventura</surname><given-names>M.</given-names></name><name><surname>Canchaya</surname><given-names>C.</given-names></name><name><surname>Tauch</surname><given-names>A.</given-names></name><name><surname>Chandra</surname><given-names>G.</given-names></name><name><surname>Fitzgerald</surname><given-names>G.F.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>van Sinderen</surname><given-names>D.</given-names></name></person-group><article-title>Genomics of <italic>Actinobacteria</italic>: Tracing the evolutionary history of an ancient phylum</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2007</year><volume>71</volume><fpage>495</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00005-07</pub-id><?supplied-pmid 17804669?><pub-id pub-id-type="pmid">17804669</pub-id></element-citation></ref><ref id="B5-antibiotics-10-00403"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Escribano</surname><given-names>J.P.</given-names></name><name><surname>Alt</surname><given-names>S.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name></person-group><article-title>Next generation sequencing of actinobacteria for the discovery of novel natural products</article-title><source>Mar. Drugs.</source><year>2016</year><volume>14</volume><elocation-id>78</elocation-id><pub-id pub-id-type="doi">10.3390/md14040078</pub-id></element-citation></ref><ref id="B6-antibiotics-10-00403"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Steinke</surname><given-names>K.</given-names></name><name><surname>Villebro</surname><given-names>R.</given-names></name><name><surname>Ziemert</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Medema</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name></person-group><article-title>antiSMASH 5.0: Updates to the secondary metabolite genome mining pipeline</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id></element-citation></ref><ref id="B7-antibiotics-10-00403"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautsar</surname><given-names>S.A.</given-names></name><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J.C.</given-names></name><name><surname>Terlouw</surname><given-names>B.R.</given-names></name><name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name><name><surname>van Santen</surname><given-names>J.A.</given-names></name><name><surname>Tracanna</surname><given-names>V.</given-names></name><name><surname>Suarez Duran</surname><given-names>H.G.</given-names></name><name><surname>Pascal Andreu</surname><given-names>V.</given-names></name><etal/></person-group><article-title>MIBiG 2.0: A repository for biosynthetic gene clusters of known function</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>454</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz882</pub-id></element-citation></ref><ref id="B8-antibiotics-10-00403"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Santen</surname><given-names>J.A.</given-names></name><name><surname>Kautsar</surname><given-names>S.A.</given-names></name><name><surname>Medema</surname><given-names>M.H.</given-names></name><name><surname>Linington</surname><given-names>R.G.</given-names></name></person-group><article-title>Microbial natural products databases: Moving forward in the multi-omics era</article-title><source>Nat. Prod. Rep.</source><year>2021</year><volume>38</volume><fpage>264</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1039/D0NP00053A</pub-id><pub-id pub-id-type="pmid">32856641</pub-id></element-citation></ref><ref id="B9-antibiotics-10-00403"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genilloud</surname><given-names>O.</given-names></name></person-group><article-title>Mining actinomycetes for novel antibiotics in the omics era: Are we ready to exploit this new paradigm?</article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>85</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7040085</pub-id></element-citation></ref><ref id="B10-antibiotics-10-00403"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloosterman</surname><given-names>A.M.</given-names></name><name><surname>Cimermancic</surname><given-names>P.</given-names></name><name><surname>Elsayed</surname><given-names>S.S.</given-names></name><name><surname>Du</surname><given-names>C.</given-names></name><name><surname>Hadjithomas</surname><given-names>M.</given-names></name><name><surname>Donia</surname><given-names>M.S.</given-names></name><name><surname>Fischbach</surname><given-names>M.A.</given-names></name><name><surname>van Wezel</surname><given-names>G.P.</given-names></name><name><surname>Medema</surname><given-names>M.H.</given-names></name></person-group><article-title>Expansion of RiPP biosynthetic space through integration of pan-genomics and machine learning uncovers a novel class of lanthipeptides</article-title><source>PLoS Biol.</source><year>2020</year><volume>18</volume><pub-id pub-id-type="doi">10.1371/journal.pbio.3001026</pub-id><?supplied-pmid 33351797?><pub-id pub-id-type="pmid">33351797</pub-id></element-citation></ref><ref id="B11-antibiotics-10-00403"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnison</surname><given-names>P.G.</given-names></name><name><surname>Bibb</surname><given-names>M.J.</given-names></name><name><surname>Bierbaum</surname><given-names>G.</given-names></name><name><surname>Bowers</surname><given-names>A.A.</given-names></name><name><surname>Bugni</surname><given-names>T.S.</given-names></name><name><surname>Bulaj</surname><given-names>G.</given-names></name><name><surname>Camarero</surname><given-names>J.A.</given-names></name><name><surname>Campopiano</surname><given-names>D.J.</given-names></name><name><surname>Challis</surname><given-names>G.L.</given-names></name><name><surname>Clardy</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>108</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1039/C2NP20085F</pub-id><?supplied-pmid 23165928?><pub-id pub-id-type="pmid">23165928</pub-id></element-citation></ref><ref id="B12-antibiotics-10-00403"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortiz-L&#x000f3;pez</surname><given-names>F.J.</given-names></name><name><surname>Carretero-Molina</surname><given-names>D.</given-names></name><name><surname>S&#x000e1;nchez-Hidalgo</surname><given-names>M.</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>J.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>I.</given-names></name><name><surname>Rom&#x000e1;n-Hurtado</surname><given-names>F.</given-names></name><name><surname>de la Cruz</surname><given-names>M.</given-names></name><name><surname>Garc&#x000ed;a-Fern&#x000e1;ndez</surname><given-names>S.</given-names></name><name><surname>Reyes</surname><given-names>F.</given-names></name><name><surname>Deisinger</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Cacaoidin, first member of the new lanthidin RiPP family</article-title><source>Angew. Chem. Int. Ed.</source><year>2020</year><volume>59</volume><fpage>12654</fpage><lpage>12658</lpage><pub-id pub-id-type="doi">10.1002/anie.202005187</pub-id><?supplied-pmid 32407589?><pub-id pub-id-type="pmid">32407589</pub-id></element-citation></ref><ref id="B13-antibiotics-10-00403"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Vel&#x000e1;squez</surname><given-names>J.E.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Evolution of lanthipeptide synthetases</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>18361</fpage><lpage>18366</lpage><pub-id pub-id-type="doi">10.1073/pnas.1210393109</pub-id><?supplied-pmid 23071302?><pub-id pub-id-type="pmid">23071302</pub-id></element-citation></ref><ref id="B14-antibiotics-10-00403"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Linaridin natural products</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>37</volume><fpage>1152</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1039/C9NP00074G</pub-id><pub-id pub-id-type="pmid">32484193</pub-id></element-citation></ref><ref id="B15-antibiotics-10-00403"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repka</surname><given-names>L.M.</given-names></name><name><surname>Chekan</surname><given-names>J.R.</given-names></name><name><surname>Nair</surname><given-names>S.K.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Mechanistic understanding of lanthipeptide biosynthetic enzymes</article-title><source>Chem. Rev.</source><year>2017</year><volume>117</volume><fpage>5457</fpage><lpage>5520</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00591</pub-id><?supplied-pmid 28135077?><pub-id pub-id-type="pmid">28135077</pub-id></element-citation></ref><ref id="B16-antibiotics-10-00403"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rateb</surname><given-names>M.E.</given-names></name><name><surname>Zhai</surname><given-names>Y.</given-names></name><name><surname>Ehrner</surname><given-names>E.</given-names></name><name><surname>Rath</surname><given-names>C.M.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Tabudravu</surname><given-names>J.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name><name><surname>Kyeremeh</surname><given-names>K.</given-names></name><name><surname>Dorrestein</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>Legonaridin, a new member of linaridin RiPP from a Ghanaian <italic>Streptomyces</italic> isolate</article-title><source>Org. Biomol. Chem.</source><year>2015</year><volume>13</volume><fpage>9585</fpage><lpage>9592</lpage><pub-id pub-id-type="doi">10.1039/C5OB01269D</pub-id><pub-id pub-id-type="pmid">26256511</pub-id></element-citation></ref><ref id="B17-antibiotics-10-00403"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sit</surname><given-names>C.S.</given-names></name><name><surname>Yoganathan</surname><given-names>S.</given-names></name><name><surname>Vederas</surname><given-names>J.C.</given-names></name></person-group><article-title>Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates</article-title><source>Acc. Chem. Res.</source><year>2011</year><volume>44</volume><fpage>261</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1021/ar1001395</pub-id><pub-id pub-id-type="pmid">21366289</pub-id></element-citation></ref><ref id="B18-antibiotics-10-00403"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claesen</surname><given-names>J.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name></person-group><article-title>Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>16297</fpage><lpage>16302</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008608107</pub-id><pub-id pub-id-type="pmid">20805503</pub-id></element-citation></ref><ref id="B19-antibiotics-10-00403"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>W.-Q.</given-names></name><name><surname>Ji</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Biosynthetic insights into linaridin natural products from genome mining and precursor peptide mutagenesis</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>1484</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1021/acschembio.7b00262</pub-id><pub-id pub-id-type="pmid">28452467</pub-id></element-citation></ref><ref id="B20-antibiotics-10-00403"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Cheng</surname><given-names>Z.</given-names></name><name><surname>Bashiri</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>S.-X.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Functional genome mining reveals a novel class V lanthipeptide containing a D-amino acid introduced by an F<sub>420</sub>H<sub>2</sub>-dependent reductase</article-title><source>Angew. Chem. Int. Ed.</source><year>2020</year><volume>59</volume><fpage>18029</fpage><lpage>18035</lpage><pub-id pub-id-type="doi">10.1002/anie.202008035</pub-id></element-citation></ref><ref id="B21-antibiotics-10-00403"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M.</given-names></name><name><surname>Scott</surname><given-names>T.A.</given-names></name><name><surname>Ramesh</surname><given-names>S.</given-names></name><name><surname>Rahman</surname><given-names>I.R.</given-names></name><name><surname>van Heel</surname><given-names>A.J.</given-names></name><name><surname>Viel</surname><given-names>J.H.</given-names></name><name><surname>Bandarian</surname><given-names>V.</given-names></name><name><surname>Dittmann</surname><given-names>E.</given-names></name><name><surname>Genilloud</surname><given-names>O.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>New developments in RiPP discovery, enzymology and engineering</article-title><source>Nat. Prod. Rep.</source><year>2020</year><volume>38</volume><fpage>130</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1039/D0NP00027B</pub-id><pub-id pub-id-type="pmid">32935693</pub-id></element-citation></ref><ref id="B22-antibiotics-10-00403"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Heel</surname><given-names>A.J.</given-names></name><name><surname>de Jong</surname><given-names>A.</given-names></name><name><surname>Song</surname><given-names>C.</given-names></name><name><surname>Viel</surname><given-names>J.H.</given-names></name><name><surname>Kok</surname><given-names>J.</given-names></name><name><surname>Kuipers</surname><given-names>O.P.</given-names></name></person-group><article-title>BAGEL4: A user-friendly web server to thoroughly mine RiPPs and bacteriocins</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>46</volume><fpage>278</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1093/nar/gky383</pub-id></element-citation></ref><ref id="B23-antibiotics-10-00403"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skinnider</surname><given-names>M.A.</given-names></name><name><surname>Merwin</surname><given-names>N.J.</given-names></name><name><surname>Johnston</surname><given-names>C.W.</given-names></name><name><surname>Magarvey</surname><given-names>N.A.</given-names></name></person-group><article-title>PRISM 3: Expanded prediction of natural product chemical structures from microbial genomes</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx320</pub-id><?supplied-pmid 28460067?><pub-id pub-id-type="pmid">28460067</pub-id></element-citation></ref><ref id="B24-antibiotics-10-00403"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Mo</surname><given-names>T.</given-names></name><name><surname>Mandalapu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group><article-title>Substrate specificity of the cypemycin decarboxylase CypD</article-title><source>Synth. Syst. Biotechnol.</source><year>2018</year><volume>3</volume><fpage>159</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2018.09.002</pub-id><?supplied-pmid 30345401?><pub-id pub-id-type="pmid">30345401</pub-id></element-citation></ref><ref id="B25-antibiotics-10-00403"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Shin</surname><given-names>I.</given-names></name><name><surname>Rhee</surname><given-names>S.</given-names></name></person-group><article-title>Crystal structure of the effector protein HopA1 from <italic>Pseudomonas syringae</italic></article-title><source>J. Struct. Biol.</source><year>2015</year><volume>189</volume><fpage>276</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1016/j.jsb.2015.02.002</pub-id><pub-id pub-id-type="pmid">25681297</pub-id></element-citation></ref><ref id="B26-antibiotics-10-00403"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acedo</surname><given-names>J.Z.</given-names></name><name><surname>Bothwell</surname><given-names>I.R.</given-names></name><name><surname>An</surname><given-names>L.</given-names></name><name><surname>Trouth</surname><given-names>A.</given-names></name><name><surname>Frazier</surname><given-names>C.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>O-methyltransferase-mediated incorporation of a &#x003b2;-amino acid in lanthipeptides</article-title><source>J. Am. Chem. Soc.</source><year>2019</year><volume>141</volume><fpage>16790</fpage><lpage>16801</lpage><pub-id pub-id-type="doi">10.1021/jacs.9b07396</pub-id><?supplied-pmid 31568727?><pub-id pub-id-type="pmid">31568727</pub-id></element-citation></ref><ref id="B27-antibiotics-10-00403"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Acedo</surname><given-names>J.Z.</given-names></name><name><surname>Estrada</surname><given-names>P.</given-names></name><name><surname>Nair</surname><given-names>S.K.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Characterization of a dehydratase and methyltransferase in the biosynthesis of a ribosomally-synthesized and post-translationally modified peptide in <italic>Lachnospiraceae</italic></article-title><source>ChemBioChem</source><year>2019</year><volume>21</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1002/cbic.201900483</pub-id><pub-id pub-id-type="pmid">31532570</pub-id></element-citation></ref><ref id="B28-antibiotics-10-00403"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Post-translational introduction of D-alanine into ribosomally synthesized peptides by the dehydroalanine reductase NpnJ</article-title><source>J. Am. Chem. Soc.</source><year>2015</year><volume>137</volume><fpage>12426</fpage><lpage>12429</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b05207</pub-id><?supplied-pmid 26361061?><pub-id pub-id-type="pmid">26361061</pub-id></element-citation></ref><ref id="B29-antibiotics-10-00403"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohans</surname><given-names>C.T.</given-names></name><name><surname>Li</surname><given-names>J.L.</given-names></name><name><surname>Vederas</surname><given-names>J.C.</given-names></name></person-group><article-title>Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids</article-title><source>J. Am. Chem. Soc.</source><year>2014</year><volume>136</volume><fpage>13150</fpage><lpage>13153</lpage><pub-id pub-id-type="doi">10.1021/ja5070813</pub-id><pub-id pub-id-type="pmid">25207953</pub-id></element-citation></ref><ref id="B30-antibiotics-10-00403"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>L.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Discovery and characterization of bicereucin, an unusual D-amino acid-containing mixed two-component lantibiotic</article-title><source>J. Am. Chem. Soc.</source><year>2016</year><volume>138</volume><fpage>5254</fpage><lpage>5257</lpage><pub-id pub-id-type="doi">10.1021/jacs.6b02513</pub-id><pub-id pub-id-type="pmid">27074593</pub-id></element-citation></ref><ref id="B31-antibiotics-10-00403"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girauld</surname><given-names>M.F.</given-names></name><name><surname>Naismith</surname><given-names>J.H.</given-names></name></person-group><article-title>The rhamnose pathway</article-title><source>Curr. Opin. Struct. Biol.</source><year>2000</year><volume>19</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/S0959-440X(00)00145-7</pub-id></element-citation></ref><ref id="B32-antibiotics-10-00403"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galm</surname><given-names>U.</given-names></name><name><surname>Wendt-Pienkowski</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>S.-X.</given-names></name><name><surname>Unsin</surname><given-names>C.</given-names></name><name><surname>Tao</surname><given-names>M.</given-names></name><name><surname>Coughlin</surname><given-names>J.M.</given-names></name><name><surname>Shen</surname><given-names>B.</given-names></name></person-group><article-title>Comparative analysis of the biosynthetic gene clusters and pathways for three structurally related antitumor antibiotics: Bleomycin, tallosomycin and zorbamycin</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>526</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1021/np1008152</pub-id><pub-id pub-id-type="pmid">21210656</pub-id></element-citation></ref><ref id="B33-antibiotics-10-00403"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Varki</surname><given-names>A.</given-names></name><name><surname>Cummings</surname><given-names>R.D.</given-names></name><name><surname>Esko</surname><given-names>J.D.</given-names></name><name><surname>Freeze</surname><given-names>H.H.</given-names></name><name><surname>Stanley</surname><given-names>P.</given-names></name><name><surname>Bertozzi</surname><given-names>C.R.</given-names></name><name><surname>Hart</surname><given-names>G.W.</given-names></name><name><surname>Etzler</surname><given-names>M.E.</given-names></name></person-group><source>Essentials of Glycobiology</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1999</year></element-citation></ref><ref id="B34-antibiotics-10-00403"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Williamson</surname><given-names>R.T.</given-names></name><name><surname>Shen</surname><given-names>B.</given-names></name><name><surname>Graziani</surname><given-names>E.I.</given-names></name><name><surname>Yang</surname><given-names>H.Y.</given-names></name><name><surname>Sakya</surname><given-names>S.M.</given-names></name><name><surname>Petersen</surname><given-names>P.J.</given-names></name><name><surname>Carter</surname><given-names>G.T.</given-names></name></person-group><article-title>Mannopeptimycins, novel antibacterial glycopeptides from <italic>Streptomyces hygroscopicus</italic>, LL-AC98</article-title><source>J. Am. Chem. Soc.</source><year>2002</year><volume>124</volume><fpage>9729</fpage><lpage>9736</lpage><pub-id pub-id-type="doi">10.1021/ja020257s</pub-id><pub-id pub-id-type="pmid">12175230</pub-id></element-citation></ref><ref id="B35-antibiotics-10-00403"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brockhausen</surname><given-names>I.</given-names></name><name><surname>Ho</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Lau</surname><given-names>K.</given-names></name><name><surname>Szarek</surname><given-names>W.A.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Feng</surname><given-names>L.</given-names></name></person-group><article-title>Characterization of two &#x003b2;-1,3-glucosyltransferases from <italic>Escherichia coli</italic> serotypes O56 and O152</article-title><source>J. Bacteriol.</source><year>2008</year><volume>190</volume><fpage>4922</fpage><lpage>4932</lpage><pub-id pub-id-type="doi">10.1128/JB.00160-08</pub-id><?supplied-pmid 18487334?><pub-id pub-id-type="pmid">18487334</pub-id></element-citation></ref><ref id="B36-antibiotics-10-00403"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradel</surname><given-names>E.</given-names></name><name><surname>Parker</surname><given-names>C.T.</given-names></name><name><surname>Schnaitman</surname><given-names>C.A.</given-names></name></person-group><article-title>Structures of the <italic>rfaB, rfaI, rfaJ</italic>, and <italic>rfaS</italic> genes of <italic>Escherichia coli</italic> K-12 and their roles in assembly of the lipopolysaccharide core</article-title><source>J. Bacteriol.</source><year>1992</year><volume>174</volume><fpage>4736</fpage><lpage>4745</lpage><pub-id pub-id-type="doi">10.1128/JB.174.14.4736-4745.1992</pub-id><?supplied-pmid 1624461?><pub-id pub-id-type="pmid">1624461</pub-id></element-citation></ref><ref id="B37-antibiotics-10-00403"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salcedo</surname><given-names>R.G.</given-names></name><name><surname>Olano</surname><given-names>C.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name><name><surname>Bra&#x000f1;a</surname><given-names>A.F.</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name><name><surname>de la Calle</surname><given-names>F.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>Elucidation of the glycosylation steps during biosynthesis of antitumor macrolides PM100117 and PM100118 and engineering for novel derivatives</article-title><source>Microb. Cell Fact.</source><year>2016</year><volume>15</volume><fpage>187</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0591-7</pub-id><?supplied-pmid 27829451?><pub-id pub-id-type="pmid">27829451</pub-id></element-citation></ref><ref id="B38-antibiotics-10-00403"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salem</surname><given-names>S.M.</given-names></name><name><surname>Weidenbach</surname><given-names>S.</given-names></name><name><surname>Rohr</surname><given-names>J.</given-names></name></person-group><article-title>Two cooperative glycosyltransferases are responsible for the sugar diversity of saquayamycins isolated from <italic>Streptomyces</italic> sp. KY 40-1</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>2529</fpage><lpage>2534</lpage><pub-id pub-id-type="doi">10.1021/acschembio.7b00453</pub-id><pub-id pub-id-type="pmid">28892347</pub-id></element-citation></ref><ref id="B39-antibiotics-10-00403"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malmierca</surname><given-names>M.G.</given-names></name><name><surname>P&#x000e9;rez-Victoria</surname><given-names>I.</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>J.</given-names></name><name><surname>Reyes</surname><given-names>F.</given-names></name><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name><name><surname>Olano</surname><given-names>C.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>Cooperative involvement of glycosyltransferases in the transfer of amino sugars during the biosynthesis of the macrolactam sipanmycin by <italic>Streptomyces</italic> sp. strain CS149</article-title><source>Appl. Environ. Microbiol.</source><year>2018</year><volume>84</volume><pub-id pub-id-type="doi">10.1128/AEM.01462-18</pub-id></element-citation></ref><ref id="B40-antibiotics-10-00403"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaunietis</surname><given-names>A.</given-names></name><name><surname>Buivydas</surname><given-names>A.</given-names></name><name><surname>Citavicius</surname><given-names>D.J.</given-names></name><name><surname>Kuipers</surname><given-names>O.P.</given-names></name></person-group><article-title>Heterologous biosynthesis and characterization of a glycocin from a thermophilic bacterium</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>1115</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09065-5</pub-id><?supplied-pmid 30846700?><pub-id pub-id-type="pmid">30846700</pub-id></element-citation></ref><ref id="B41-antibiotics-10-00403"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Substrate tolerance of the biosynthetic enzymes of glycosylated lanthipeptide NAI-112</article-title><source>Org. Biomol. Chem.</source><year>2020</year><volume>18</volume><fpage>6095</fpage><lpage>6099</lpage><pub-id pub-id-type="doi">10.1039/D0OB01215G</pub-id><?supplied-pmid 32700722?><pub-id pub-id-type="pmid">32700722</pub-id></element-citation></ref><ref id="B42-antibiotics-10-00403"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plat</surname><given-names>A.</given-names></name><name><surname>Kluskens</surname><given-names>L.D.</given-names></name><name><surname>Kuipers</surname><given-names>A.</given-names></name><name><surname>Rink</surname><given-names>R.</given-names></name><name><surname>Moll</surname><given-names>G.N.</given-names></name></person-group><article-title>Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage</article-title><source>Appl. Environ. Microbiol.</source><year>2011</year><volume>77</volume><fpage>604</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1128/AEM.01503-10</pub-id><?supplied-pmid 21097596?><pub-id pub-id-type="pmid">21097596</pub-id></element-citation></ref><ref id="B43-antibiotics-10-00403"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knerr</surname><given-names>P.J.</given-names></name><name><surname>van der Donk</surname><given-names>W.A.</given-names></name></person-group><article-title>Discovery, biosynthesis, and engineering of lantipeptides</article-title><source>Annu. Rev. Biochem.</source><year>2012</year><volume>81</volume><fpage>479</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-060110-113521</pub-id><?supplied-pmid 22404629?><pub-id pub-id-type="pmid">22404629</pub-id></element-citation></ref><ref id="B44-antibiotics-10-00403"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iorio</surname><given-names>M.</given-names></name><name><surname>Sasso</surname><given-names>O.</given-names></name><name><surname>Maffioli</surname><given-names>S.I.</given-names></name><name><surname>Bertorelli</surname><given-names>R.</given-names></name><name><surname>Monciardini</surname><given-names>P.</given-names></name><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Bonezzi</surname><given-names>F.</given-names></name><name><surname>Summa</surname><given-names>M.</given-names></name><name><surname>Brunati</surname><given-names>C.</given-names></name><name><surname>Bordoni</surname><given-names>R.</given-names></name><etal/></person-group><article-title>A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity</article-title><source>ACS Chem. Biol.</source><year>2014</year><volume>9</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1021/cb400692w</pub-id><?supplied-pmid 24191663?><pub-id pub-id-type="pmid">24191663</pub-id></element-citation></ref><ref id="B45-antibiotics-10-00403"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>E.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name><name><surname>Ge</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name></person-group><article-title>Zn-dependent bifunctional proteases are responsible for leader peptide processing of class III lanthipeptides</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>2533</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1073/pnas.1815594116</pub-id><?supplied-pmid 30679276?><pub-id pub-id-type="pmid">30679276</pub-id></element-citation></ref><ref id="B46-antibiotics-10-00403"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krawczyk</surname><given-names>J.M.</given-names></name><name><surname>V&#x000f6;ller</surname><given-names>G.-H.</given-names></name><name><surname>Krawczyk</surname><given-names>B.</given-names></name><name><surname>Kretz</surname><given-names>J.</given-names></name><name><surname>Br&#x000f6;nstrup</surname><given-names>M.</given-names></name><name><surname>S&#x000fc;ssmuth</surname><given-names>R.D.</given-names></name></person-group><article-title>Heterologous expression and engineering studies of labyrinthopeptins, class III lantibiotics from <italic>Actinomadura namibiensis</italic></article-title><source>Chem. Biol.</source><year>2013</year><volume>20</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.10.023</pub-id><pub-id pub-id-type="pmid">23352145</pub-id></element-citation></ref><ref id="B47-antibiotics-10-00403"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname><given-names>C.</given-names></name><name><surname>Korn</surname><given-names>S.M.</given-names></name><name><surname>H&#x000e4;sler</surname><given-names>M.</given-names></name><name><surname>Peetz</surname><given-names>O.</given-names></name><name><surname>Martin</surname><given-names>J.</given-names></name><name><surname>K&#x000f6;tter</surname><given-names>P.</given-names></name><name><surname>Morgner</surname><given-names>N.</given-names></name><name><surname>Entian</surname><given-names>K.-D.</given-names></name></person-group><article-title>LanI-mediated lantibiotic immunity in <italic>Bacillus subtilis</italic>: Functional analysis</article-title><source>Appl. Environ. Microbiol.</source><year>2019</year><volume>85</volume><fpage>e00534-19</fpage><pub-id pub-id-type="doi">10.1128/AEM.00534-19</pub-id><pub-id pub-id-type="pmid">30952662</pub-id></element-citation></ref><ref id="B48-antibiotics-10-00403"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e9;ndez</surname><given-names>C.</given-names></name><name><surname>Salas</surname><given-names>J.A.</given-names></name></person-group><article-title>The role of ABC transporters in antibiotics-producing organisms: Drug secretion and resistance mechanisms</article-title><source>Res. Microbiol.</source><year>2001</year><volume>152</volume><fpage>341</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1016/S0923-2508(01)01205-0</pub-id><pub-id pub-id-type="pmid">11421281</pub-id></element-citation></ref><ref id="B49-antibiotics-10-00403"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>H.E.</given-names></name><name><surname>Devine</surname><given-names>K.M.</given-names></name><name><surname>McConnell</surname><given-names>D.J.</given-names></name></person-group><article-title>Characterisation of a repressor gene (<italic>xre</italic>) and a temperature-sensitive allele from the <italic>Bacillus subtilis</italic> prophage, PBSX</article-title><source>Gene</source><year>1990</year><volume>96</volume><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(90)90344-Q</pub-id><pub-id pub-id-type="pmid">2125016</pub-id></element-citation></ref><ref id="B50-antibiotics-10-00403"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuthbertson</surname><given-names>L.</given-names></name><name><surname>Nodwell</surname><given-names>J.R.</given-names></name></person-group><article-title>The TetR family of regulators</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2013</year><volume>77</volume><fpage>440</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00018-13</pub-id><?supplied-pmid 24006471?><pub-id pub-id-type="pmid">24006471</pub-id></element-citation></ref><ref id="B51-antibiotics-10-00403"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name></person-group><article-title>Role and regulation of bacterial LuxR-like regulators</article-title><source>J. Cell Biochem.</source><year>2011</year><volume>112</volume><fpage>2694</fpage><lpage>2702</lpage><pub-id pub-id-type="doi">10.1002/jcb.23219</pub-id><pub-id pub-id-type="pmid">21678467</pub-id></element-citation></ref><ref id="B52-antibiotics-10-00403"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Kong</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>You</surname><given-names>D.</given-names></name></person-group><article-title>Characterization of the positive SARP family regulator PieR for improving piericidin A1 production in <italic>Streptomyces piomogeues</italic> var. Hangzhouwanensis</article-title><source>Synth. Syst. Biotechnol.</source><year>2019</year><volume>4</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.synbio.2018.12.002</pub-id><?supplied-pmid 30560207?><pub-id pub-id-type="pmid">30560207</pub-id></element-citation></ref><ref id="B53-antibiotics-10-00403"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radauer</surname><given-names>C.</given-names></name><name><surname>Lackner</surname><given-names>P.</given-names></name><name><surname>Breiteneder</surname><given-names>H.</given-names></name></person-group><article-title>The Bet v1 fold: An ancient, versatile scaffold for binding of large, hydrophobic ligands</article-title><source>BMC Evol. Biol.</source><year>2008</year><volume>8</volume><elocation-id>286</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2148-8-286</pub-id><?supplied-pmid 18922149?><pub-id pub-id-type="pmid">18922149</pub-id></element-citation></ref><ref id="B54-antibiotics-10-00403"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>L.M.</given-names></name><name><surname>Koonin</surname><given-names>E.V.</given-names></name><name><surname>Aravind</surname><given-names>L.</given-names></name></person-group><article-title>Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily</article-title><source>Proteins</source><year>2001</year><volume>43</volume><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1002/1097-0134(20010501)43:2&#x0003c;134::AID-PROT1025&#x0003e;3.0.CO;2-I</pub-id><pub-id pub-id-type="pmid">11276083</pub-id></element-citation></ref><ref id="B55-antibiotics-10-00403"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ames</surname><given-names>B.D.</given-names></name><name><surname>Korman</surname><given-names>T.P.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Smith</surname><given-names>P.</given-names></name><name><surname>Vu</surname><given-names>T.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Tsai</surname><given-names>S.-C.</given-names></name></person-group><article-title>Crystal structure and functional analysis of tetracenomycin ARO/CYC: Implications for cyclization specificity of aromatic polyketides</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>5349</fpage><lpage>5354</lpage><pub-id pub-id-type="doi">10.1073/pnas.0709223105</pub-id><?supplied-pmid 18388203?><pub-id pub-id-type="pmid">18388203</pub-id></element-citation></ref><ref id="B56-antibiotics-10-00403"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>J.</given-names></name><name><surname>Brostromer</surname><given-names>E.</given-names></name><name><surname>Liu</surname><given-names>X.Y.</given-names></name><name><surname>Kristensen</surname><given-names>O.</given-names></name><name><surname>Su</surname><given-names>X.D.</given-names></name></person-group><article-title>Bioinformatics and structural characterization of a hypothetical protein from <italic>Streptococcus mutans</italic>: Implication of antibiotic resistance</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><elocation-id>e7245</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007245</pub-id><pub-id pub-id-type="pmid">19798411</pub-id></element-citation></ref><ref id="B57-antibiotics-10-00403"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>B.J.</given-names></name><name><surname>Hudson</surname><given-names>G.A.</given-names></name><name><surname>Dunbar</surname><given-names>K.L.</given-names></name><name><surname>Mitchell</surname><given-names>D.A.</given-names></name></person-group><article-title>A prevalent peptide-binding domain guides ribosomal natural product biosynthesis</article-title><source>Nat. Chem. Biol.</source><year>2015</year><volume>11</volume><fpage>564</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1856</pub-id><pub-id pub-id-type="pmid">26167873</pub-id></element-citation></ref><ref id="B58-antibiotics-10-00403"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinman</surname><given-names>J.P.</given-names></name><name><surname>Bonnot</surname><given-names>F.</given-names></name></person-group><article-title>Intrigues and intricacies of the biosynthetic pathways for the enzymatic quinocofactors: PQQ, TTQ, CTQ, TPQ, and LTQ</article-title><source>Chem. Rev.</source><year>2014</year><volume>114</volume><fpage>4343</fpage><lpage>4365</lpage><pub-id pub-id-type="doi">10.1021/cr400475g</pub-id><pub-id pub-id-type="pmid">24350630</pub-id></element-citation></ref><ref id="B59-antibiotics-10-00403"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latham</surname><given-names>J.A.</given-names></name><name><surname>Iavarone</surname><given-names>A.T.</given-names></name><name><surname>Barr</surname><given-names>I.</given-names></name><name><surname>Juthani</surname><given-names>P.V.</given-names></name><name><surname>Klinman</surname><given-names>J.P.</given-names></name></person-group><article-title>PqqD is a novel peptide chaperone that forms a ternary complex with the radical S-adenosylmethionine protein PqqE in the pyrroloquinoline quinone biosynthetic pathway</article-title><source>J. Biol. Chem.</source><year>2015</year><volume>290</volume><fpage>12908</fpage><lpage>12918</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.646521</pub-id><pub-id pub-id-type="pmid">25817994</pub-id></element-citation></ref><ref id="B60-antibiotics-10-00403"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Wilde</surname><given-names>L.C.</given-names></name></person-group><article-title><italic>Streptomyces albus</italic> G mutants defective in the SalGI restriction-modification system</article-title><source>J. Gen. Microbiol.</source><year>1980</year><volume>116</volume><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1099/00221287-116-2-323</pub-id><pub-id pub-id-type="pmid">6246193</pub-id></element-citation></ref><ref id="B61-antibiotics-10-00403"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Gabrieli</surname><given-names>T.</given-names></name><name><surname>Lou</surname><given-names>G.</given-names></name><name><surname>Ebenstein</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>T.F.</given-names></name></person-group><article-title>Cas9-assisted targeting of chromosome segments CATCH enables one-step targeted cloning of large gene clusters</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>8101</fpage><pub-id pub-id-type="doi">10.1038/ncomms9101</pub-id><pub-id pub-id-type="pmid">26323354</pub-id></element-citation></ref><ref id="B62-antibiotics-10-00403"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Reynolds</surname><given-names>K.A.</given-names></name><name><surname>Kersten</surname><given-names>R.D.</given-names></name><name><surname>Ryan</surname><given-names>K.S.</given-names></name><name><surname>Gonzalez</surname><given-names>D.J.</given-names></name><name><surname>Nizet</surname><given-names>V.</given-names></name><name><surname>Dorrestein</surname><given-names>P.C.</given-names></name><name><surname>Moore</surname><given-names>B.S.</given-names></name></person-group><article-title>Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>1957</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1073/pnas.1319584111</pub-id><pub-id pub-id-type="pmid">24449899</pub-id></element-citation></ref><ref id="B63-antibiotics-10-00403"><label>63.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kieser</surname><given-names>T.</given-names></name><name><surname>Bibb</surname><given-names>M.J.</given-names></name><name><surname>Buttner</surname><given-names>M.J.</given-names></name><name><surname>Chater</surname><given-names>K.F.</given-names></name><name><surname>Hopwood</surname><given-names>D.A.</given-names></name></person-group><source>Practical Streptomyces Genetics</source><publisher-name>John Innes Foundation</publisher-name><publisher-loc>Norwich, UK</publisher-loc><year>2002</year><volume>Volume 291</volume></element-citation></ref><ref id="B64-antibiotics-10-00403"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilyk</surname><given-names>B.</given-names></name><name><surname>Luzhetskyy</surname><given-names>A.</given-names></name></person-group><article-title>Unusual site-specific DNA integration into the highly active pseudo-<italic>attB</italic> of the <italic>Streptomyces albus</italic> J1074 genome</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2014</year><volume>98</volume><fpage>5095</fpage><lpage>5104</lpage><pub-id pub-id-type="doi">10.1007/s00253-014-5605-y</pub-id><pub-id pub-id-type="pmid">24566921</pub-id></element-citation></ref><ref id="B65-antibiotics-10-00403"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>K.</given-names></name></person-group><article-title>Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G + C-content biases</article-title><source>Mol. Biol. Evol.</source><year>1992</year><volume>9</volume><fpage>678</fpage><lpage>687</lpage><?supplied-pmid 1630306?><pub-id pub-id-type="pmid">1630306</pub-id></element-citation></ref><ref id="B66-antibiotics-10-00403"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitou</surname><given-names>N.</given-names></name><name><surname>Nei</surname><given-names>M.</given-names></name></person-group><article-title>The neighbor-joining method: A new method for reconstructing phylogenetic trees</article-title><source>Mol. Biol. Evol.</source><year>1987</year><volume>4</volume><fpage>406</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.molbev.a040454</pub-id><?supplied-pmid 3447015?><pub-id pub-id-type="pmid">3447015</pub-id></element-citation></ref><ref id="B67-antibiotics-10-00403"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente</surname><given-names>C.M.</given-names></name><name><surname>Thibessard</surname><given-names>A.</given-names></name><name><surname>Lorenzi</surname><given-names>J.-N.</given-names></name><name><surname>Benhadj</surname><given-names>M.</given-names></name><name><surname>H&#x000f4;tel</surname><given-names>L.</given-names></name><name><surname>Gacemi-Kirane</surname><given-names>D.</given-names></name><name><surname>Lespinet</surname><given-names>O.</given-names></name><name><surname>Leblond</surname><given-names>P.</given-names></name><name><surname>Aigle</surname><given-names>B.</given-names></name></person-group><article-title>Comparative genomics among closely related <italic>Streptomyces</italic> strains revealed specialized metabolite biosynthetic gene cluster diversity</article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>86</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7040086</pub-id></element-citation></ref><ref id="B68-antibiotics-10-00403"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seipke</surname><given-names>R.F.</given-names></name></person-group><article-title>Strain-level diversity of secondary metabolism in <italic>Streptomyces albus</italic></article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0116457</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0116457</pub-id><pub-id pub-id-type="pmid">25635820</pub-id></element-citation></ref><ref id="B69-antibiotics-10-00403"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudoir</surname><given-names>M.J.</given-names></name><name><surname>Pepe-Ranney</surname><given-names>C.</given-names></name><name><surname>Buckley</surname><given-names>D.H.</given-names></name></person-group><article-title>Diversification of secondary metabolite biosynthetic gene clusters coincides with lineage divergence in <italic>Streptomyces</italic></article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7010012</pub-id><?supplied-pmid 29438308?><pub-id pub-id-type="pmid">29438308</pub-id></element-citation></ref><ref id="B70-antibiotics-10-00403"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.J.</given-names></name><name><surname>Yamanaka</surname><given-names>K.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Moore</surname><given-names>B.S.</given-names></name></person-group><article-title>Direct cloning and heterologous expression of natural product biosynthetic gene clusters by transformation-associated recombination</article-title><source>Methods Enzymol.</source><year>2019</year><volume>621</volume><fpage>87</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2019.02.026</pub-id><?supplied-pmid 31128791?><pub-id pub-id-type="pmid">31128791</pub-id></element-citation></ref><ref id="B71-antibiotics-10-00403"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koren</surname><given-names>S.</given-names></name><name><surname>Walenz</surname><given-names>B.P.</given-names></name><name><surname>Berlin</surname><given-names>K.</given-names></name><name><surname>Miller</surname><given-names>J.R.</given-names></name><name><surname>Bergman</surname><given-names>N.H.</given-names></name><name><surname>Phillippy</surname><given-names>A.M.</given-names></name></person-group><article-title>Canu: Scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation</article-title><source>Genome Res.</source><year>2017</year><volume>27</volume><fpage>722</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1101/gr.215087.116</pub-id><?supplied-pmid 28298431?><pub-id pub-id-type="pmid">28298431</pub-id></element-citation></ref><ref id="B72-antibiotics-10-00403"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>B.J.</given-names></name><name><surname>Abeel</surname><given-names>T.</given-names></name><name><surname>Shea</surname><given-names>T.</given-names></name><name><surname>Priest</surname><given-names>M.</given-names></name><name><surname>Abouelliel</surname><given-names>A.</given-names></name><name><surname>Sakthikumar</surname><given-names>S.</given-names></name><name><surname>Cuomo</surname><given-names>C.A.</given-names></name><name><surname>Zeng</surname><given-names>Q.</given-names></name><name><surname>Wortman</surname><given-names>J.</given-names></name><name><surname>Young</surname><given-names>S.K.</given-names></name><etal/></person-group><article-title>Pilon: An Integrated Tool for Comprehensive Microbial Variant Detection and Genome Assembly Improvement</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e112963</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0112963</pub-id><pub-id pub-id-type="pmid">25409509</pub-id></element-citation></ref><ref id="B73-antibiotics-10-00403"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>P.</given-names></name><name><surname>Khater</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name><name><surname>Sain</surname><given-names>N.</given-names></name><name><surname>Mohanty</surname><given-names>D.</given-names></name></person-group><article-title>RiPPMiner: A bioinformatics resource for deciphering chemical structures of RiPPs based on prediction of cleavage and cross-links</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>W80</fpage><lpage>W88</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx408</pub-id><pub-id pub-id-type="pmid">28499008</pub-id></element-citation></ref><ref id="B74-antibiotics-10-00403"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>M.</given-names></name><name><surname>Zaretskaya</surname><given-names>I.</given-names></name><name><surname>Raytselis</surname><given-names>Y.</given-names></name><name><surname>Merezhuk</surname><given-names>Y.</given-names></name><name><surname>McGinnis</surname><given-names>S.</given-names></name><name><surname>Madden</surname><given-names>T.L.</given-names></name></person-group><article-title>NCBI BLAST: A better web interface</article-title><source>Nucleic Acids Res.</source><year>2008</year><volume>36</volume><fpage>W5</fpage><lpage>W9</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn201</pub-id><?supplied-pmid 18440982?><pub-id pub-id-type="pmid">18440982</pub-id></element-citation></ref><ref id="B75-antibiotics-10-00403"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>L.</given-names></name><name><surname>Stephens</surname><given-names>A.</given-names></name><name><surname>Nam</surname><given-names>S.-Z.</given-names></name><name><surname>Rau</surname><given-names>D.</given-names></name><name><surname>K&#x000fc;bler</surname><given-names>J.</given-names></name><name><surname>Lozajic</surname><given-names>M.</given-names></name><name><surname>Gabler</surname><given-names>F.</given-names></name><name><surname>S&#x000f6;ding</surname><given-names>J.</given-names></name><name><surname>Lupas</surname><given-names>A.N.</given-names></name><name><surname>Alva</surname><given-names>V.</given-names></name></person-group><article-title>A Completely Reimplemented MPI Bioinformatics Toolkit with a New HHpred Server at its Core</article-title><source>J. Mol. Biol.</source><year>2018</year><volume>2836</volume><fpage>30587</fpage><lpage>30589</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2017.12.007</pub-id></element-citation></ref><ref id="B76-antibiotics-10-00403"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jian</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>T.F.</given-names></name></person-group><article-title>Targeted isolation and cloning of 100-kb microbial genomic sequences by Cas9-assisted targeting of chromosome segments</article-title><source>Nat. Protoc.</source><year>2016</year><volume>11</volume><fpage>960</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.055</pub-id><?supplied-pmid 27101517?><pub-id pub-id-type="pmid">27101517</pub-id></element-citation></ref><ref id="B77-antibiotics-10-00403"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Robertsen</surname><given-names>H.L.</given-names></name><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name></person-group><article-title>CRISPR-Cas9 Toolkit for Actinomycete Genome Editing</article-title><source>Methods Mol. Biol.</source><year>2018</year><volume>1671</volume><fpage>163</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-7295-1_11</pub-id><?supplied-pmid 29170959?><pub-id pub-id-type="pmid">29170959</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-10-00403-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structure of cacaoidin before (<bold>top</bold>) and after (<bold>bottom</bold>) the Post-Translational Modifications (PTMs). In the modified cacaoidin, absolute configuration for NMe2Ala(S)-1 is tentatively proposed as (2S) (equivalently, <sc>d</sc>-Ala). The amino acids modified by biosynthetic enzymes are colored in pink, the glycosylated tyrosine is colored in yellow, and the non-modified amino acids are colored in blue.</p></caption><graphic xlink:href="antibiotics-10-00403-g001"/></fig><fig id="antibiotics-10-00403-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Schematic representation of the BGC of cacaoidin, where <italic>caoA</italic> codes for the precursor peptide. The sequences of the leader and core peptides of cacaoidin are shown.</p></caption><graphic xlink:href="antibiotics-10-00403-g002"/></fig><fig id="antibiotics-10-00403-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>(<bold>a</bold>) Chromatograms of UV absorbance at 210 nm (blue trace) and extracted ion <italic>m</italic>/<italic>z</italic> = 793.0571 &#x000b1; 0.003, C<sub>107</sub>H<sub>162</sub>N<sub>24</sub>O<sub>32</sub>S<sub>2</sub> + NH<sub>4</sub><sup>+</sup> + 2H<sup>+</sup> of cacaoidin (MDN-0207) from original producing strain <italic>Streptomyces cacaoi</italic> CA-170360 and the heterologous producing strain <italic>Streptomyces albus</italic> J1074 /pCAO. (<bold>b</bold>) Experimental UV and positive mass spectra from C<sub>107</sub>H<sub>162</sub>N<sub>24</sub>O<sub>32</sub>S<sub>2</sub> + NH<sub>4</sub><sup>+</sup> + 2H<sup>+</sup> (calculated value: 793.0571) (<bold>top</bold>) and C<sub>107</sub>H<sub>162</sub>N<sub>24</sub>O<sub>32</sub>S<sub>2</sub> + 2NH<sub>4</sub><sup>+</sup> (calculated value: 1197.5952) (<bold>bottom</bold>) adducts from heterologous producing strain (<bold>right</bold>) and from original producing strain CA-170360 (<bold>left</bold>).</p></caption><graphic xlink:href="antibiotics-10-00403-g003"/></fig><fig id="antibiotics-10-00403-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>(<bold>a</bold>) Tandem MS/MS fragmentation pattern of C<sub>107</sub>H<sub>162</sub>N<sub>24</sub>O<sub>32</sub>S<sub>2</sub> + NH<sub>4</sub><sup>+</sup> + 2H<sup>+</sup> from strain CA-170360 (<bold>top</bold>) and <italic>S. albus</italic> J1074/pCAO (<bold>bottom</bold>). Annotation of b-, y- and z-ions is shown. (<bold>b</bold>) Key MS/MS fragmentation of [M + 2H + NH<sub>4</sub>]<sup>3+</sup> ion.</p></caption><graphic xlink:href="antibiotics-10-00403-g004"/></fig><fig id="antibiotics-10-00403-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Schematic representation of the alignment of cacaoidin BGC from <italic>Streptomyces cacaoi</italic> CA-170360 and the highly homologous clusters found in NCBI. All of them belong as well to strains of <italic>S. cacaoi</italic>. A: <italic>S. cacaoi</italic> CA-170360; B: <italic>S. cacaoi</italic> subsp. <italic>cacaoi</italic> NBRC 12748; C: <italic>Streptomyces</italic> sp. NRRL S-1868; D: <italic>Streptomyces</italic> sp. NRRL F-5053; E: <italic>S. cacaoi</italic> subsp. cacaoi NRRL B-1220; F: <italic>S. cacaoi</italic> subsp. <italic>cacaoi</italic> OABC16.</p></caption><graphic xlink:href="antibiotics-10-00403-g005"/></fig><fig id="antibiotics-10-00403-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Schematic representation of cacaoidin BGC and the BGC of lexapeptide and other putative lanthidins (class V lanthipeptides). Accession numbers of each putative structural peptide are indicated.</p></caption><graphic xlink:href="antibiotics-10-00403-g006"/></fig><fig id="antibiotics-10-00403-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Alignment of cacaoidin and putative lanthidins (class V lanthipeptides) precursor peptides (accession numbers are shown). Sequence logo shows conserved residues.</p></caption><graphic xlink:href="antibiotics-10-00403-g007"/></fig><table-wrap id="antibiotics-10-00403-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">antibiotics-10-00403-t001_Table 1</object-id><label>Table 1</label><caption><p>Closest BLAST homolog for each Open Reading Frame (ORF) in cacaoidin Biosythetic Gene Cluster (BGC).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ORF</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Closest BLAST Homolog</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">%Identity/<break/>Similarity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Conserved Domains</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Possible Function</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoR1</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DNA-binding response regulator [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CitB (NarL/FixJ family, contains REC and HTH domains); HTH_LUXR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive regulator</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoR2</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Helix-turn-helix domain-containing protein [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.44/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HTH_XRE superfamily</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative regulator</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao3</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein SCA03_05120 [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.81/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RmlD_sub_bind</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sc>l-</sc>rhamnose synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao4</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyltransferase [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methyltrans_2 (O-methyltransferase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N-terminal dimethylation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao5</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDP-mannose 4,6-dehydratase [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.16/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">dTDP_GD_SDR-e (dDTP-<sc>d</sc>-glucose 4,6-dehydratase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sc>l</sc>-rhamnose biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao6</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MULTISPECIES: glucose-1-phosphate thymidylyltransferase [<italic>Streptomyces</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">RmlA_long (glucose-1-phosphate thymidylyltransferase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sc>l</sc>-rhamnose biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao7</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HopA1 superfamily</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao8</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycosyltransferase family 2 protein [<italic>Streptomyces</italic> sp. NRRL S-1868]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.48/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycos_transf_2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycosylation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao9</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phosphotransferase [<italic>Streptomyces</italic> sp. NRRL S-1868]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PKc_like (protein kinase catalytic domain)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoA</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein SCA03_05190 [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No putative conserved domains detected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Structural gene</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao11</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABC transporter ATP-binding protein [<italic>Streptomyces</italic> sp. NRRL F-5053]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.66/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MdlB (ABC-type multidrug transport system, ATPase and permease component)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacaoidin biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao12</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MULTISPECIES: LLM class flavin-dependent oxidoreductase [<italic>Streptomyces</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SsuD (Flavin-dependent oxidoreductase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacaoidin biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoD</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein SCA03_05220 [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.63/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PRK05579 (bifunctional phosphopantothenoylcysteine decarboxylase/phosphopantothenate synthase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AviMeCys biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao14</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MULTISPECIES: hypothetical protein [unclassified <italic>Streptomyces</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.34/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No putative conserved domains detected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao15</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein [<italic>Streptomyces</italic> sp. NHF165]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.42/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PqqL (predicted Zn-dependent peptidase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leader peptide cleavage</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao16</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycosyltransferase family 2 protein [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycos_transf_2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycosylation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao17</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">91.7/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No putative conserved domains detected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao18</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABC transporter ATP-binding protein [<italic>Streptomyces</italic> sp. NRRL F-5053]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CcmA (ABC-type multidrug transport system)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacaoidin biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao19</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MULTISPECIES: ABC transporter permease [<italic>Streptomyces</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.65/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ABC2_membrane_3 (ABC-2 family transporter protein)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cacaoidin biosynthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoR3</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein SCA03_05280 [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HTH_XRE domain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative regulator</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao21</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein [<italic>Streptomyces</italic> sp. NRRL S-1868]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No putative conserved domains detected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoR4</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TetR/AcrR family transcriptional regulator [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AcrR (DNA-binding transcriptional regulator)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative regulator</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao23</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein SCA03_05310 [<italic>Streptomyces cacaoi</italic> subsp. <italic>cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.39/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SRPBCC superfamily</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao24</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MULTISPECIES: glycosyltransferase family 4 protein [<italic>Streptomyces</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GT4_AmsD-like</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycosylation </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao25</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein [<italic>Streptomyces cacaoi</italic>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.06/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No putative conserved domains detected</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>cao26</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No homologues found</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>caoR5</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetratricopeptide repeat protein [<italic>Streptomyces</italic> sp. NRRL S-1868]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.31/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BTAD (Bacterial Transcriptional Activation)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive regulator</td></tr></tbody></table></table-wrap></floats-group></article>